<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69269</article-id><article-id pub-id-type="doi">10.7554/eLife.69269</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Translational control of polyamine metabolism by CNBP is required for <italic>Drosophila</italic> locomotor function</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-236334"><name><surname>Coni</surname><given-names>Sonia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0295-8904</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-236335"><name><surname>Falconio</surname><given-names>Federica A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-236336"><name><surname>Marzullo</surname><given-names>Marta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7229-1693</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236337"><name><surname>Munafò</surname><given-names>Marzia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2689-8432</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236426"><name><surname>Zuliani</surname><given-names>Benedetta</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236445"><name><surname>Mosti</surname><given-names>Federica</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231712"><name><surname>Fatica</surname><given-names>Alessandro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236340"><name><surname>Ianniello</surname><given-names>Zaira</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236428"><name><surname>Bordone</surname><given-names>Rosa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236343"><name><surname>Macone</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236344"><name><surname>Agostinelli</surname><given-names>Enzo</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236432"><name><surname>Perna</surname><given-names>Alessia</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-37776"><name><surname>Matkovic</surname><given-names>Tanja</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7213"><name><surname>Sigrist</surname><given-names>Stephan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1698-5815</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-236345"><name><surname>Silvestri</surname><given-names>Gabriella</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-236341"><name><surname>Canettieri</surname><given-names>Gianluca</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6694-2613</contrib-id><email>gianluca.canettieri@uniroma1.it</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-233889"><name><surname>Ciapponi</surname><given-names>Laura</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0817-1862</contrib-id><email>laura.ciapponi@uniroma1.it</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Molecular Medicine, Sapienza University of Rome</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff2"><label>2</label><institution>Department of Biology and Biotechnologies, Sapienza University of Rome</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution>Department of Life Sciences Imperial College London South Kensington campus</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution>IBPM CNR c/o Department of Biology and Biotechnology, Sapienza University of Rome</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff5"><label>5</label><institution>European Molecular Biology Laboratory (EMBL) Epigenetics &amp; Neurobiology Unit, Campus Adriano Buzzati-Traverso</institution><addr-line><named-content content-type="city">Monterotond</named-content></addr-line><country>Italy</country></aff><aff id="aff6"><label>6</label><institution>Department of Neurobiology, Duke University Medical Center</institution><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Department of Biochemical Sciences, Sapienza University of Rome</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff8"><label>8</label><institution>Department of Sensory Organs, Sapienza University of Rome, Policlinico Umberto I</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff9"><label>9</label><institution>International Polyamines Foundation ‘ETS-ONLUS’</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff10"><label>10</label><institution>Department of Neuroscience, Fondazione Policlinico Gemelli IRCCS, University Cattolica del S. Cuore</institution><addr-line><named-content content-type="city">Roma</named-content></addr-line><country>Italy</country></aff><aff id="aff11"><label>11</label><institution>Freie Universität Berlin, Institute for Biology and Genetics</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff12"><label>12</label><institution>Department of Scienze dell’Invecchiamento, Neurologiche, Ortopediche e della testa-Collo; UOC Neurologia, Fondazione Policlinico Universitario ‘A. Gemelli’ IRCCS</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff13"><label>13</label><institution>Pasteur Institute, Fondazione Cenci-Bolognetti</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ramaswami</surname><given-names>Mani</given-names></name><role>Reviewing Editor</role><aff><institution>Trinity College Dublin</institution><country>Ireland</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Senior Editor</role><aff><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution><country>India</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>09</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69269</elocation-id><history><date date-type="received" iso-8601-date="2021-04-09"><day>09</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-08-08"><day>08</day><month>08</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-04-30"><day>30</day><month>04</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.04.29.441910"/></event></pub-history><permissions><copyright-statement>© 2021, Coni et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Coni et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69269-v1.pdf"/><abstract><p>Microsatellite expansions of CCTG repeats in the cellular nucleic acid-binding protein (<italic>CNBP</italic>) gene leads to accumulation of toxic RNA and have been associated with myotonic dystrophy type 2 (DM2). However, it is still unclear whether the dystrophic phenotype is also linked to CNBP decrease, a conserved CCHC-type zinc finger RNA-binding protein that regulates translation and is required for mammalian development. Here, we show that depletion of <italic>Drosophila</italic> CNBP in muscles causes ageing-dependent locomotor defects that are correlated with impaired polyamine metabolism. We demonstrate that the levels of ornithine decarboxylase (ODC) and polyamines are significantly reduced upon dCNBP depletion. Of note, we show a reduction of the CNBP-polyamine axis in muscles from DM2 patients. Mechanistically, we provide evidence that dCNBP controls polyamine metabolism through binding dOdc mRNA and regulating its translation. Remarkably, the locomotor defect of dCNBP-deficient flies is rescued by either polyamine supplementation or dOdc1 overexpression. We suggest that this dCNBP function is evolutionarily conserved in vertebrates with relevant implications for CNBP-related pathophysiological conditions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>CNBP</kwd><kwd>myotonic dystrophy 2</kwd><kwd>polyamine</kwd><kwd>translation</kwd><kwd>ODC</kwd><kwd><italic>Drosophila melanogaster</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004923</institution-id><institution>AFM-Téléthon</institution></institution-wrap></funding-source><award-id>21025</award-id><principal-award-recipient><name><surname>Ciapponi</surname><given-names>Laura</given-names></name><name><surname>Canettieri</surname><given-names>Gianluca</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005010</institution-id><institution>Associazione Italiana per la Ricerca sul Cancro</institution></institution-wrap></funding-source><award-id>IG 17575</award-id><principal-award-recipient><name><surname>Canettieri</surname><given-names>Gianluca</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004271</institution-id><institution>Sapienza Università di Roma</institution></institution-wrap></funding-source><award-id>RM1181642798C54A</award-id><principal-award-recipient><name><surname>Canettieri</surname><given-names>Gianluca</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004588</institution-id><institution>Istituto Pasteur-Fondazione Cenci Bolognetti</institution></institution-wrap></funding-source><award-id>Anna Tramontano</award-id><principal-award-recipient><name><surname>Canettieri</surname><given-names>Gianluca</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A decrease of the type 2 myotonic dystrophy gene product CNBP causes an impairment of polyamine metabolism and locomotor dysfunction that can be reverted with polyamine supplementation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Myotonic dystrophy (DM) is the most common inherited muscle dystrophy in adults and comprises two genetically distinct forms: DM type 1 (DM1, Steinert’ disease, OMIM 160900), caused by an expansion of CTG repeats in the 3′ untranslated region of the DM protein kinase (<italic>DMPK</italic>) gene (<xref ref-type="bibr" rid="bib6">Brook et al., 1992</xref>) and DM type 2 (DM2, OMIM 602668), due to the expansion of CCTG repeats in the first intron of the cellular nucleic acid-binding protein (<italic>CNBP</italic>) gene, also named <italic>ZNF9</italic> (zinc finger protein 9; <xref ref-type="bibr" rid="bib29">Liquori et al., 2001</xref>). Both DM1 and DM2 display a multisystemic involvement of the skeletal muscle, heart, eye, brain, endocrine system, and smooth muscle. The similarities in the clinical features have led to the hypothesis of a common pathogenic mechanism, represented by toxic gain-of-function of RNAs transcribed from alleles containing expanded CUG or CCUG repeats. These RNAs are ubiquitously transcribed, folded into hairpin structures and accumulated in nuclear foci, affecting the function of RNA-binding proteins such as the muscleblind-like proteins (MBNL1-3) and CUG-binding protein 1 (CUG-BP1) that regulates alternative splicing (<xref ref-type="bibr" rid="bib26">Kanadia et al., 2006</xref>; <xref ref-type="bibr" rid="bib32">Mohan et al., 2014</xref>). Recently, the involvement of additional non‐mutually exclusive mechanisms, such as bi-directional antisense transcription, alteration of microRNA expression, and non-ATG-mediated translation (RAN) have been demonstrated (<xref ref-type="bibr" rid="bib10">Cho et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Juźwik et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Moseley et al., 2006</xref>; <xref ref-type="bibr" rid="bib35">Nguyen et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Perbellini et al., 2011</xref>). In particular, ectopic RAN translation has been reported in several degenerative diseases caused by microsatellite expansions such as SCA8 (spinocerebellar ataxia type 8), DM1, fragile X-associated tremor ataxia syndrome (FXTAS), C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD), Fuchs endothelial corneal dystrophy, SCA31 (spinocerebellar ataxia type 31), Huntington disease, and recently in DM2 (<xref ref-type="bibr" rid="bib52">Zu et al., 2011</xref>; <xref ref-type="bibr" rid="bib53">Zu et al., 2013</xref>; <xref ref-type="bibr" rid="bib33">Mori et al., 2013</xref>; <xref ref-type="bibr" rid="bib3">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Todd et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Bañez-Coronel et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Zu et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Ishiguro et al., 2017</xref>; <xref ref-type="bibr" rid="bib46">Soragni et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Nguyen et al., 2019</xref>).</p><p>The presence of a repeat expansion might also lead to loss-of-function of the protein encoded by the affected mRNA. Haploinsufficiency of <italic>CNBP</italic> gene, resulting from the nuclear sequestration and/or altered processing of expanded pre-mRNAs, has been proposed to play an important role in the pathogenesis of DM2. In mice, heterozygous deletion of one <italic>CNBP</italic> allele causes a phenotype reminiscent of DM2 myopathy that gets worse with age, while homozygous deletion causes muscle atrophy and severe locomotor dysfunction already in young mice (<xref ref-type="bibr" rid="bib9">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="bib50">Wei et al., 2018</xref>). Studies on muscle tissues or myoblasts from DM2 patients provided controversial results: some studies found normal <italic>CNBP m</italic>RNA and protein levels in muscle tissues (<xref ref-type="bibr" rid="bib40">Raheem et al., 2010</xref>), while recent findings documented decreased protein levels in muscle tissues (<xref ref-type="bibr" rid="bib22">Huichalaf et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Raheem et al., 2010</xref>; <xref ref-type="bibr" rid="bib42">Salisbury et al., 2009</xref>; <xref ref-type="bibr" rid="bib44">Schneider-Gold and Timchenko, 2010</xref>; <xref ref-type="bibr" rid="bib50">Wei et al., 2018</xref>). The hypothesis that CNBP deficiency plays a key role in DM2 pathogenesis implies that perturbation of CNBP function contributes to this disease.</p><p>CNBP is a highly conserved ssDNA-binding protein of 19 kDa (<xref ref-type="bibr" rid="bib7">Calcaterra et al., 2010</xref>) involved in the control of both transcription, by binding to ssDNA and unfolding G-quadruplex DNAs (G4-DNAs) in the nuclei, and translation, by binding to mRNA and unfolding G4-related structures in the cytosol (<xref ref-type="bibr" rid="bib2">Armas et al., 2008</xref>; <xref ref-type="bibr" rid="bib5">Benhalevy et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">David et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Huichalaf et al., 2009</xref>; <xref ref-type="bibr" rid="bib23">Iadevaia et al., 2008</xref>; <xref ref-type="bibr" rid="bib28">Leipheimer et al., 2018</xref>). Additionally, CNBP promotes internal ribosome entry site (IRES)-dependent translation of the ornithine decarboxylase (ODC) mRNA working as IRES-transacting factor (ITAF; <xref ref-type="bibr" rid="bib18">Gerbasi and Link, 2007</xref>; <xref ref-type="bibr" rid="bib43">Sammons et al., 2011</xref>). In our previous studies, we found that CNBP promotes IRES-mediated translation of ODC and polyamine metabolism in neurons and that this mechanism is aberrantly activated in the medulloblastoma (<xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>). Hence, these studies highlighted the ability of CNBP to control polyamine metabolism and illustrated the consequence of an aberrant function of this molecular regulatory mechanism in human disease.</p><p>Polyamines (putrescine, spermidine, and spermine) are ubiquitous positively charged aliphatic amines that control key aspects of cell biology, such as cell growth, cell death, replication, translation, differentiation, and autophagy (<xref ref-type="bibr" rid="bib8">Casero et al., 2018</xref>; <xref ref-type="bibr" rid="bib11">Coni et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Wallace, 2000</xref>). Polyamine metabolism starts from the decarboxylation of ornithine into putrescine, then putrescine is converted into spermidine, which is in turn transformed into spermine (<xref ref-type="bibr" rid="bib8">Casero et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Wallace et al., 2003</xref>). Because of their critical role, the intracellular concentration of polyamines is tightly regulated. Conversion of ornithine into putrescine, catalyzed by ODC, an enzyme with an evolutionarily conserved function, represents the rate limiting step (<xref ref-type="bibr" rid="bib43">Sammons et al., 2011</xref>; <xref ref-type="bibr" rid="bib49">Wallace et al., 2003</xref>). Indeed, the intracellular levels of ODC are promptly adjusted to the cellular needs, thanks to different mechanisms affecting its protein stability, transcription, and translation (<xref ref-type="bibr" rid="bib37">Pegg, 2006</xref>). Alterations of polyamine content are found in different pathophysiological conditions such as cancer, degenerative disorders, and aging (<xref ref-type="bibr" rid="bib8">Casero et al., 2018</xref>), although their specific role in muscle disorders has not been fully characterized yet.</p><p>Given the conservation of CNBP primary structure and function between <italic>Drosophila melanogaster</italic> and vertebrates/humans (<xref ref-type="bibr" rid="bib1">Antonucci et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>) in this work, we have investigated the effect of <italic>CNBP</italic> loss-of-function. We show that dCNBP depletion in muscles reduces fly viability and causes a robust locomotor defect. Furthermore, we demonstrate that dCNBP directly affects polyamine metabolism by regulating dOdc mRNA translation and, notably, that restoration of proper polyamine content rescues muscle function.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>CNBP</italic> is essential for fly locomotion</title><p>To explore the role of CNBP, we conducted RNAi-mediated knockdown experiments of <italic>Drosophila dCNBP</italic> gene. As previously shown, the expression of two copies of the RNAi construct (2XUAS<italic>dCNBP<sup>RNAi</sup></italic>) under the control of ubiquitous promoters resulted in embryonic or larval lethality (<xref ref-type="bibr" rid="bib1">Antonucci et al., 2014</xref>). Thus, to address the in vivo function of <italic>dCNBP</italic>, we drove the expression of 2XUAS<italic>dCNBP<sup>RNAi</sup></italic> using tissue-specific GAL4 drivers (<xref ref-type="table" rid="table1">Table 1</xref>). We did not observe any effect on viability or fly locomotion activity when <italic>dCNBP</italic> was silenced in neurons, motor neurons, or glia (<xref ref-type="table" rid="table1">Table 1</xref>). The efficacy of dCNBP knockdown with neuronal drivers was extremely efficient, as documented by dCNBP immunoblots from larval and adult brain lysates (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Conversely, the expression of 2XUAS<italic>dCNBP<sup>RNAi</sup></italic> driven by the multi-tissue <italic>69B-GAL4</italic> or the muscle-specific <italic>myocyte enhancer factor 2 (Mef2)-GAL4</italic> drivers caused early lethality at 29°C (<xref ref-type="table" rid="table1">Table 1</xref>). At 25°C or 18°C, lethality was reduced, allowing phenotypic analysis of adult ‘escapers’. Adult flies carrying 2XUAS-<italic>dCNBP<sup>RNAi</sup></italic> and either <italic>Mef2-GAL4</italic> or <italic>69B-GAL4</italic> showed strong locomotion defects, as denoted by the strong reduction of speed (0.01 <italic>versus</italic> 0.09 cm/s) and distance covered in 1 min (0.67 <italic>versus</italic> 8 cm) observed in silenced flies compared to controls (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>, <xref ref-type="video" rid="fig1video2">2</xref>, <xref ref-type="video" rid="fig1video3">3</xref>; <xref ref-type="bibr" rid="bib20">Gulyás et al., 2016</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Specific <italic>dCNBP</italic> depletion in muscle tissues results in locomotor defects.</title><p>(<bold>A</bold>) Locomotion activity in escapers adult flies expressing (<bold>B</bold>) <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) driven by the <italic>myocyte enhancer factor 2 (Mef2)-GAL4</italic> at 25°C, compared to control flies (<italic>no UAS</italic>). Fly movements were recorded (<xref ref-type="video" rid="fig1video1">Figure 1—video 1</xref>, <xref ref-type="video" rid="fig1video2">2</xref>, <xref ref-type="video" rid="fig1video3">3</xref>) and then analyzed by the animal tracker ImageJ plugin, to quantify both fly speed (average, cm/s) and distance covered in 1 min (<xref ref-type="bibr" rid="bib20">Gulyás et al., 2016</xref>). (<bold>C</bold>) Climbing activity defects in adult flies expressing 2X<italic>dCNBP<sup>RNAi</sup></italic> driven by the <italic>mhc-GAL4</italic> at 29°C. The locomotion activity was measured by the <italic>Drosophila</italic> activity monitoring (DAM) system, as the number of climbing events in 30 min ≥ 80 males tested for each genotype. On the left, climbing performance of control flies (<italic>no UAS</italic>) or <italic>dCNBP</italic>-depleted flies (2X<italic>dCNBP<sup>RNAi</sup></italic>) 7 days after eclosion represented as the average of climbing events (CEs) in 30 min (error bars represent SEM; ****p<italic>&lt;</italic>0.0001, Mann-Whitney-Wilcoxon test). On the right, quantitative grouping of climbing performances in four different classes. Classes 1–20 (white area) and 20–50 (light gray area) CEs are highly represented in RNAi flies (<italic>2XdCNBP<sup>RNAi</sup></italic>), while classes 50–100 CEs (dark gray area) are more frequent in control flies (<italic>no UAS</italic>). Only control flies have the ability to perform more than 100 CEs in 30 min (black area). Full data in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>. (<bold>D</bold>) Box plot representation of the distribution of peristaltic contraction rates performed in 1 min by control (<italic>no UAS</italic>) or <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) third instar larvae under the control of either <italic>c179GAL4</italic> or <italic>24BGAL4</italic> driver at 25°C (****p&lt;0.0001, t-test); ≥10 larvae tested for each genotype in at least three independent experiments. Full data in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>. (<bold>E</bold>) Box plot representation of the distribution of peristaltic contraction rates performed by control (<italic>wild-type [WT]</italic>) or <italic>cnbp<sup>k</sup></italic> mutant second instar larvae in 1 min; ≥30 larvae tested for each genotype (p <italic>&lt;</italic> 0.0001, Mann-Whitney-Wilcoxon test). In (<bold>C and D</bold>) the line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range. Full data in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>. (<bold>F</bold>) Immunoblot showing the levels of dCNBP in extract obtained from <italic>cnbp<sup>k</sup></italic> mutant second instar or from WT control larvae with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. A.U., arbitrary unit.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Adult and larval movement measurements as shown in <xref ref-type="fig" rid="fig1">Figure 1B-D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>dCNBP knockdown efficacy in absence of phenotype.</title><p>Immunoblot showing the levels of dCNBP in extract obtained from larval brains or adult heads of <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) individuals, where the knockdown is driven by either the n<italic>-syb</italic> or the <italic>elav</italic> GAL4 drivers at 25°C, compared to control (<italic>no UAS</italic>). On the right a graph showing the corresponding band quantification, normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Tubulin, loading control. A.U., arbitrary unit.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig1-figsupp1-v1.tif"/></fig><media id="fig1video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-69269-fig1-video1.mp4"><label>Figure 1—video 1.</label><caption><title>Example of locomotor movement of a control adult fly (<italic>myocyte enhancer factor 2 [Mef2]-GAL4</italic> &gt; <italic>no UAS</italic> at 25°C).</title></caption></media><media id="fig1video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-69269-fig1-video2.mp4"><label>Figure 1—video 2.</label><caption><title><bold>Example of locomotor defects of a dCNBP-interfered adult fly</bold> (<italic>myocyte enhancer factor 2 [Mef2]-GAL4</italic> &gt; <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> at 25°C).</title></caption></media><media id="fig1video3" mime-subtype="mp4" mimetype="video" xlink:href="elife-69269-fig1-video3.mp4"><label>Figure 1—video 3.</label><caption><title>Second example of locomotor defects of a dCNBP-interfered adult fly (myocyte enhancer factor 2 [Mef2]-GAL4&gt;UAS-dCNBPRNAi-16283; UAS-dCNBPRNAi-16284at25°C).</title></caption></media></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Effects of dCNBP silencing using different tissue-specific GAL4 drivers.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Driver line</th><th valign="top">Expression pattern</th><th valign="top"><italic>2XdCNBP<sup>RNAi</sup></italic> at 29°C</th><th valign="top"><italic>2XdCNBP<sup>RNAi</sup></italic> at 25°C</th></tr></thead><tbody><tr><td><italic>tubulin-GAL4</italic></td><td valign="top">Constitutive-ubiquitous</td><td valign="top">Embryonic lethal</td><td valign="top">Larval lethal (third instar)</td></tr><tr><td><italic>actin-GAL4</italic></td><td valign="top">Constitutive-ubiquitous</td><td valign="top">Embryonic lethal</td><td valign="top">Larval lethal (third instar)</td></tr><tr><td><italic>elav-GAL4</italic></td><td valign="top">Pan-neuronal</td><td valign="top">No locom. phenotype</td><td valign="top">NT</td></tr><tr><td><italic>nrv-GAL4</italic></td><td valign="top">Pan-neuronal specific in CNS and PNS</td><td valign="top">No locom. phenotype</td><td valign="top">NT</td></tr><tr><td><italic>D42-GAL4</italic></td><td valign="top">Motor neurons</td><td valign="top">No locom. phenotype</td><td valign="top">NT</td></tr><tr><td><italic>n-syb-GAL4</italic></td><td valign="top">Pan-neuronal</td><td valign="top">No locom. phenotype</td><td valign="top">NT</td></tr><tr><td><italic>repo-GAL4</italic></td><td valign="top">Glia</td><td valign="top">No locom. phenotype</td><td valign="top">NT</td></tr><tr><td><italic>69B-GAL4</italic></td><td valign="top">Embryonic epiderm, CNS, and imaginal discs</td><td valign="top">Larval lethal (first instar)</td><td valign="top">Larval lethal. Escapers with locom. defects at 18°C</td></tr><tr><td><italic>mhc-GAL4</italic></td><td valign="top">Myosin heavy chain promoter</td><td valign="top">Reduced climbing activity</td><td valign="top">NT</td></tr><tr><td><italic>Mef2-GAL4</italic></td><td valign="top">Somatic muscle cells, embryonic mesoderm (stages 10–17), embryonic cardioblast</td><td valign="top">Embryonic lethal</td><td valign="top">Semi-lethal (pupal stage) Escapers with locom. defects</td></tr><tr><td><italic>c179-GAL4</italic></td><td valign="top">Embryonic mesoderm and larval muscles</td><td valign="top">Reduced larval activity</td><td valign="top">Pupal lethal</td></tr><tr><td><italic>how<sup>24B</sup>-GAL4</italic></td><td valign="top">Embryonic mesoderm. Precursors of the somatic muscles, visceral muscles, and cardiac cells. Larval nuclei of muscle fibers.</td><td valign="top">Reduced larval activity</td><td valign="top">Pupal lethal</td></tr><tr><td><italic>GMR-GAL4</italic></td><td valign="top">Eye imaginal disc</td><td valign="top">Retinal degeneration</td><td valign="top">NT</td></tr><tr><td><italic>nub-GAL4</italic></td><td valign="top">Wing imaginal disc</td><td valign="top">Wing size reduction and lost of patterning elements</td><td valign="top">Wing size reduction</td></tr><tr><td><italic>5053</italic> GAL4</td><td valign="top">Embryonic longitudinal visceral muscle founder cells</td><td valign="top">Vital and no adult locomotor phenotype</td><td valign="top">NT</td></tr><tr><td><italic>sr<sup>md710</sup>-GAL4</italic></td><td valign="top">Embryonic and larval tendon cells. No expression in muscle or muscle precursors</td><td valign="top">Vital and no adult locomotor phenotype</td><td valign="top">NT</td></tr></tbody></table></table-wrap><p>To study the effects of <italic>CNBP</italic> knockdown in differentiated muscle, we utilized an <italic>mhc</italic>-GAL4 driver, which induces the expression of transgenes later during muscle development, compared to <italic>Mef2-GAL4</italic>. Although these flies were viable, they showed defective locomotion, indicating that the integrity of <italic>dCNBP</italic> expression is required for locomotor activity also at later stages of muscle development. Wild-type flies usually display a strong negative geotactic response: when tapped to the bottom of a vial they rapidly run to the top. As they get older or manifest locomotion dysfunction, flies no longer climb to the top of the vial, but make short abortive climbs and fall back to the bottom. The climbing activity of <italic>mhcGAL4&gt;</italic>2XUAS<italic>dCNBP<sup>RNAi</sup></italic> flies was measured using the <italic>Drosophila</italic> activity monitoring (DAM) system (TriKinetics Inc, Waltham, MA; see Materials and methods), which allows to quantify fly locomotion capabilities based on their negative geotactic response. As shown in <xref ref-type="fig" rid="fig1">Figure 1B</xref>, <italic>mhcGAL4&gt;</italic>2XUAS<italic>dCNBP<sup>RNAi</sup></italic> flies exhibited a strong reduction (~50%) in the number of climbing events performed in 30 min compared to control flies.</p><p>We also investigated the consequences of <italic>dCNBP</italic> silencing in the embryonic mesoderm and larval muscles. RNAi constructs expressed under the control of the c<italic>179-</italic> or <italic>how<sup>24B</sup>-GAL4</italic> drivers (<xref ref-type="table" rid="table1">Table 1</xref>) caused late pupal lethality at both 25°C and 29°C (<xref ref-type="table" rid="table1">Table 1</xref>). We thus analyzed the activity of RNAi-expressing larvae by measuring the numbers of peristaltic waves performed in 1 min. As shown in <xref ref-type="fig" rid="fig1">Figure 1C</xref>, both drivers caused a significant reduction of peristaltic waves compared to controls.</p><p>To further validate our findings and exclude that the phenotype could be linked to non-specific RNAi effects, we turned to an on-locus loss-of-function allele (dubbed <italic>dCNBP<sup>k</sup></italic>). <italic>dCNBP<sup>k</sup></italic> carries a P element insertion in the <italic>dCNBP</italic> locus (<italic>CG3800</italic>) causing lethality when homozygous (larvae die at the second instar). <italic>dCNBP<sup>k</sup></italic> mutant larvae were examined for the expression of the dCNBP by immunoblotting and for their locomotor phenotype. We found that in these larvae the <italic>dCNBP</italic> product is completely absent compared to wild type (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). We analyzed the locomotion activity of <italic>dCNBP<sup>k</sup></italic> mutant larvae by measuring the numbers of peristaltic waves/min. As shown in <xref ref-type="fig" rid="fig1">Figure 1D</xref>, we found that, consistent with the RNAi data, <italic>dCNBP</italic> mutant larvae displayed a significant reduction of peristaltic waves compared to wild-type controls.</p><p>To further confirm that locomotor defects are a specific consequence of dCNBP depletion, we generated transgenic flies bearing an RNAi-resistant cDNA (UAS<italic>dCNBP-3HAres</italic>) which contains appropriate synonymous substitutions in the <italic>dCNBP</italic> coding sequence to be resistant to RNAi-mediated degradation. Expression of this construct under the control of the <italic>c179-GAL4</italic> driver rescued larval dCNBP loss-dependent locomotor phenotype (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), confirming that this phenotype is specifically caused by <italic>dCNBP</italic> depletion.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Cellular nucleic acid-binding protein (CNBP) overexpression rescues the locomotion phenotype induced by muscular <italic>dCNBP</italic> depletion.</title><p><italic>dCNBP</italic> knockdown in embryonic mesoderm causes a significant reduction of larval peristaltic waves rescued by the expression of either <italic>dCNBP</italic> or <italic>hCNBP</italic> transgenes (25°C). (<bold>A</bold>) Box plot representation of the distribution of peristaltic contraction rates performed by third instar larvae of the following genotypes: only <italic>c179GAL4</italic> driver (<italic>no UAS</italic>), <italic>c179GAL4</italic>&gt;<italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>), <italic>c179GAL4&gt;</italic>2X<italic>dCNBP<sup>RNAi</sup> + UAS-dCNBP-3HA-res</italic> (a <italic>dCNBP-3HA</italic> transgene resistant to 2X<italic>UASdCNBP</italic>-induced RNAi), <italic>c179GAL4</italic>&gt;2X<italic>dCNBP<sup>RNAi</sup></italic> + UAS-<italic>hCNBP-FLAG</italic>. The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (****p&lt;0.0001, Kruskal-Wallis with post hoc Dunn’s test); ≥10 larvae tested for each genotype in at least three independent experiments. Full data in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>. (<bold>B</bold>) The expression levels of both <italic>UAS-dCNBP-3HA-res</italic> and UAS-<italic>hCNBP-FLAG</italic> were analyzed by immunoblotting using antibodies against either the HA or the FLAG tag, compared to controls (<italic>no UAS</italic>). Bands were quantified by IMAGE J 1.50i and normalized on the loading control (quantification data in source data for western blot [WB] quantification). Tubulin, loading control. A.U., arbitrary unit.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Larval movement measurements as shown in <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig2-v1.tif"/></fig><p>We next investigated whether the human CNBP (hCNBP) orthologue could functionally rescue the prominent <italic>dCNBP</italic> phenotype, by expressing a <italic>UAS hCNBP-FLAG</italic> construct in the <italic>Drosophila</italic> muscle by using the <italic>c179-GAL4</italic> driver. As shown in <xref ref-type="fig" rid="fig2">Figure 2A</xref>, hCNBP reversed the locomotion defects of the <italic>dCNBP<sup>RNAi</sup></italic>-depleted larvae (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), indicating that hCNBP locomotor function is evolutionarily conserved from fly to human. The expression level of both transgenes were verified and quantified by western blot (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p></sec><sec id="s2-2"><title>The ODC-polyamine pathway is involved in CNBP loss-of-function locomotor phenotype and is downregulated in muscles from DM2 patients</title><p>Having found that the absence of dCNBP in muscle tissues causes significant locomotor defects, we next sought to identify the CNBP-regulated mechanisms responsible for the observed phenotype.</p><p>Since we had previously found that mammalian CNBP regulates polyamine metabolism by affecting translation of ODC in cancer cells (<xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Sammons et al., 2011</xref>; <xref ref-type="bibr" rid="bib5">Benhalevy et al., 2017</xref>), we asked if a similar mechanism could play a role in this context.</p><p>We performed western blotting analysis of <italic>dCNBP</italic>-deficient larvae and observed that the levels of Odc are significantly reduced in larvae lacking dCNBP (in both <italic>dCNBP</italic> RNAi-expressing and <italic>cnbp<sup>k</sup></italic> mutant larvae, <xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, respectively), compared to wild-type controls. Accordingly, the content of putrescine, the downstream product of Odc enzymatic activity, was strongly reduced (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), confirming that dCNBP also regulates Odc and polyamine levels in flies.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>CNBP regulates the ornithine decarboxylase (ODC)/polyamine axis.</title><p>Levels of both Odc and putrescine are significantly reduced in <italic>dCNBP</italic>-depleted larvae compared to wild-type controls. (<bold>A</bold>) Immunoblot showing the levels of both dCNBP and dOdc in extract obtained from <italic>tubGAL4&gt;</italic>2X<italic>dCNBP<sup>RNAi</sup></italic> third instar larvae compared to control (<italic>no UAS)</italic>, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. A.U., arbitrary unit. (<bold>B</bold>) Columns represent the fold difference of putrescine content in third instar larvae bearing the <italic>c179GAL4</italic> driver alone (<italic>no UAS</italic>) or in combination with double copy dCNBP RNAi-expressing larvae (<italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup>,</italic> named 2X<italic>dCNBP<sup>RNAi</sup></italic>). Error bars represent SEM; ***p&gt;0.001, ** p&gt;0.002, in unpaired t-test. A pool of 10 larvae has been tested for each genotype in three independent experiments. Full data in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Putrescine content quantification as shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Larval locomotor defect observed in <italic>cnbp<sup>k</sup></italic> mutants correlates with the reduction of ornithine decarboxylase (Odc) protein and polyamine levels.</title><p>Levels ofOdc protein and polyamine are significantly reduced in <italic>dCNBP</italic> mutant larvae compared to wild-type (WT) controls. (<bold>A</bold>) Immunoblot showing the levels of both dCNBP and dOdc in extract obtained from <italic>WT</italic> and <italic>cnbp<sup>k</sup></italic> mutant second instar larvae, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. (<bold>B</bold>) Columns represent the fold difference of putrescine content in second instar larvae of <italic>cnbp<sup>k</sup></italic> mutant compared to controls (<italic>WT</italic>). Error bars represent SEM; **p&gt;0.002, t-test. A pool of 10 larvae has been tested for each genotype in three independent experiments. Full data in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To determine whether the locomotion defect caused by CNBP deficiency is linked to this mechanism, we analyzed the consequences of <italic>dOdc</italic> loss-of-function. We achieved an RNAi-mediated repression of both fly <italic>Odc</italic> genes, singularly or together (<italic>dOdc1</italic> and <italic>dOdc2</italic>; <xref ref-type="bibr" rid="bib41">Rom and Kahana, 1993</xref>), by crossing RNAi lines (VDRC 30039 and 104597) to the <italic>c179GAL4</italic> driver (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). <italic>Odc</italic> depletion caused adult lethality while in larvae displayed a significant impairment of peristaltic waves linked to larval locomotion activity and reduction of putrescine levels (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Interestingly, putrescine reduction was significant in both <italic>dOdc1</italic> and <italic>dOdc2</italic> single or double knockdown, but not additive. This latter observation was likely attributable to the activation of compensatory mechanisms, such as the increased uptake of extracellular polyamines through specific transporters and/or intracellular polyamine interconversion (<xref ref-type="bibr" rid="bib8">Casero et al., 2018</xref>), which prevent the total depletion of intracellular polyamines even in case of complete ODC blockade.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Ornithine decarboxylase (Odc) depletion phenocopies the <italic>dCNBP</italic> locomotor defects.</title><p>Box plot representation of the distribution of peristaltic contraction rates performed by third instar larvae of the reported genotypes in 1 min. (<bold>A</bold>) <italic>c179GAL4</italic>&gt;<italic>no UAS</italic>, <italic>UAS-Odc1<sup>RNAi-30039</sup>, UAS-Odc2<sup>RNAi-10459</sup>, UAS-Odc2<sup>RNAi-10459</sup>; UAS-Odc1<sup>RNAi-30039</sup>, or UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic>. In the graph legend UAS in transgenic RNAi lines is omitted for simplicity. (<bold>B</bold>) Controls (<italic>wild type</italic>) and <italic>dOdc1<sup>MI10996</sup></italic> mutant larvae. (<bold>C</bold>) Controls fed with standard fly food (<italic>wild type</italic>) or after DFMO treatment (5 mM/day; <italic>wild type + DFMO</italic>). The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (**p&lt;0.001; ****p&lt;0.0001; ns, not significant, Kruskal-Wallis with post hoc Dunn’s test for multiple comparison or Mann-Whitney-Wilcoxon test for); ≥10 larvae tested for each genotype in at least three independent experiments. All full data in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Larval movement measurements as shown in <xref ref-type="fig" rid="fig4">Figure 4A-C</xref> and putrescine content quantification as shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Larval locomotor defect observed as a consequence of ornithine decarboxylase (Odc) depletion correlates with the reduction of polyamine levels.</title><p>Columns represent the fold difference of putrescine content in third instar larvae of the following genotypes: only <italic>c179GAL4</italic> driver (<italic>no UAS</italic>), <italic>c179GAL4</italic>&gt;<italic>UAS-dOdc1<sup>RNAi-30039</sup></italic> (<italic>dOdc1<sup>RNAi</sup></italic>), <italic>c179GAL4&gt;UAS-dOdc2<sup>RNAi-10459</sup></italic> (<italic>dOdc2<sup>RNAi</sup></italic>), <italic>c179GAL4</italic>&gt;<italic>UAS-dOdc2<sup>RNAi-10459</sup>; UAS-dOdc1<sup>RNAi-30039</sup></italic> (<italic>dOdc1+2<sup>RNAi</sup></italic>) (error bars represent SEM; ***p&gt;0.001 with respect to the <italic>no UAS</italic> control, t-test). A pool of 10 larvae has been tested for each genotype in at least three independent experiments. Full data in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Similarly, d<italic>Odc1<sup>MI10996</sup></italic> (Bloomington #56103) mutant flies displayed significant locomotor defects associated with polyamine decrease (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), and feeding of wild-type flies with DFMO, an irreversible ODC inhibitor, caused a significant reduction of larval motility (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) demonstrating that genetic or pharmacological inhibition of dOdc strongly phenocopies dCNBP downregulation effects.</p><p>To determine if the ODC-polyamine axis is impaired also in the human disease, we studied muscle biopsies obtained from DM2 patients compared to those from healthy individuals. Remarkably, immunoblot analysis showed that the levels of both CNBP and ODC were reduced in DM2 patients compared to controls (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Consistently, we found that the content of the ODC metabolite putrescine was also significantly reduced in DM2 patients, thus indicating that polyamine synthesis might indeed be downregulated in these patients (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Polyamine metabolism is impaired also in myotonic dystrophy type 2 (DM2) muscles.</title><p>Cellular nucleic acid-binding protein (CNBP) and ornithine decarboxylase (ODC) content correlates with polyamine levels in muscle cells from DM2 patients. (<bold>A</bold>) Immunoblot showing the levels of both human CNBP (hCNBP) and human ODC (hODC) proteins in three DM2 or control muscle cells, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Vinculin, loading control. A.U., arbitrary unit. (B) Columns represent putrescine content in muscle cells obtained from four DM2 patients (<italic>CTRL</italic>) or from four healthy individuals (<italic>DM2</italic>), expressed in ng/mg of tissue. Error bars represent SEM; **p&gt;0.001, in unpaired t-test. Full data in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Putrescine content quantification as shown in <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Expression levels of dCNBP are not affected by the expression of CCUG-expanded repeat RNA.</title><p>Immunoblot showing the levels of dCNBP in larval extract obtained from controls (<italic>no UAS</italic>) or <italic>UAS-(CCTG)<sub>200</sub></italic>, <italic>UAS-(CCTG)<sub>475</sub></italic>, <italic>UAS-(CCTG)<sub>525</sub></italic> driven by the <italic>c179GAL4</italic> driver, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Tubulin, loading control. A.U., arbitrary unit. A pool of 10 larvae has been tested for each genotype in at least two independent experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig5-figsupp1-v1.tif"/></fig></fig-group><p>In contrast, the levels of CNBP were not altered in a transgenic fly model of DM2 that ectopically expresses pure, uninterrupted CCUG-repeat expansions ranging from 200 to 575 repeats in length (BDSC 79583-79584-79585) and recapitulates some key features of human DM2 including RNA repeat-induced toxicity, ribonuclear foci formation, and changes in alternative splicing (<xref ref-type="bibr" rid="bib51">Yu et al., 2015</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). These results suggest that the observed CNBP downregulation in DM2 patients is not due to the toxic RNA accumulation, but is rather a consequence of a different mechanism, specifically related to the intronic alteration. Unfortunately, the limited amount of patient samples did not allow us to investigate the mechanism underlying this downregulation. Further studies with muscle samples from patients will be required to elucidate this issue.</p></sec><sec id="s2-3"><title>dCNBP regulates dOdc translation</title><p>We next investigated the molecular mechanisms through which dCNBP controls <italic>dOdc</italic> expression and consequently polyamine metabolism.</p><p>We did not observe any significant reduction of <italic>dOdc</italic> mRNA levels in dCNBP RNAi-depleted muscles (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), indicating that CNBP does not regulate <italic>dOdc</italic> mRNA synthesis or stability but rather its protein levels. In this regard, since our previous data in mammalian cells indicated that CNBP regulates IRES-dependent translation of ODC (<xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>), we wondered if this mechanism might also be operating in flies. To this end we cloned the 5’UTR of <italic>dOdc1</italic> into a bicistronic renilla-luciferase reporter vector, which allows detection of IRES activity and tested the ability of dCNBP to induce <italic>dOdc1</italic> IRES-mediated translation. However, ectopic expression of dCNBP did not result in any significant change of reporter activity in mammalian cells, while it significantly induced the activity of a bicistronic vector containing the 5’UTR of human ODC (hODC), thus excluding that dCNBP could regulate <italic>dOdc</italic> translation through an IRES-mediated mechanism (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>dCNBP controls polyamine metabolism through the binding and the translational control of <italic>dOdc</italic> mRNA.</title><p>(<bold>A</bold>) d<italic>Odc1</italic> mRNA levels (qPCR), normalized with the housekeeping <italic>RPL11</italic> mRNA third instar larvae bearing <italic>c179GAL4</italic> driver alone (<italic>no UAS</italic>) or in combination with <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> (<italic>2XdCNBP<sup>RNAi</sup>)</italic>. ns, not significant in unpaired t-test. Dots correspond to four independent biological replicates; bars indicate the mean and SEM. (<bold>B</bold>) Cellular nucleic acid-binding protein (CNBP) binds <italic>dOdc1</italic> mRNA. qRT-PCR analysis on mRNAs immunoprecipitated by anti-dCNBP antibody or control IgG antisera in S2 cells extracts (left graph), or in dCNBP-depleted (<italic>2XdCNBP<sup>RNAi</sup></italic>) or not (<italic>no UAS</italic>) larval extracts (right graph). The results are indicated as fold difference, relative to IgG. Error bars represent SEM of three independent experiments; *p &lt; 0.05, in t-test. The presence of dCNBP in <italic>c179GAL4</italic>&gt;<italic>2XUASdCNBP<sup>RNAi</sup></italic> or control (<italic>no UAS</italic>) larval carcasses was analyzed by western blotting (right). Tubulin, loading control. (<bold>C</bold>) Representative polysome profiles (of at least three independent experiments) of dCNBP-deficient (<italic>dCNBP<sup>RNAi</sup></italic>) or control (<italic>CTRL</italic>) S2 cells. Cytoplasmic lysates were fractionated on 15–50% sucrose gradients. (<bold>D</bold>) qPCR analysis of <italic>dOdc1</italic> mRNA loaded in the different polysome fractions, GADPH was used to normalize the values. (*p &lt; 0.05, t-test. Error bars represent SEM of experiments performed in quadruplicates and repeated at least three times.) The presence of dCNBP in interfered or not interfered S2 cells was analyzed by western blotting (right). Tubulin, loading control. All full data in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Real-time qPCR data as shown in <xref ref-type="fig" rid="fig6">Figure 6A, B, D</xref>, in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A-B</xref> and in <xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4B</xref>; polysome profile data as shown in <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>dCNBP does not control polyamine metabolism through <italic>dOdc1</italic> internal ribosome entry site (IRES)-dependent translation.</title><p>(<bold>A</bold>) Schematic representation of the <italic>bicistronic CMV-renilla-TAA/dOdc1-IRES-firefly luciferase</italic> (d<italic>Odc1-luc</italic>) <italic>vector</italic> (top). The renilla ORF is translated via conventional cap-dependent mechanism, whereas translation of the luciferase ORF is controlled by the <italic>dOdc1</italic> 5’UTR sequence. IRES activity of d<italic>Odc1-luc</italic> which is not significantly modulated by dCNBP overexpression compared to the empty vector (bottom). Columns represent the fold changes of luciferase activity, normalized to the renilla expression. Error bars represent SEM; ns: no significant with Student’s t-test, of three independent experiments. (<bold>B</bold>) Schematic representation of a <italic>bicistronic CMV-renilla-TAA/hODC-IRES-firefly luciferase</italic> (<italic>hODC-luc</italic>) <italic>vector</italic> (top). IRES activity of <italic>hODC-luc</italic> which is significantly modulated by both dCNBP or hCNBP overexpression, compared to the empty vector (bottom). Columns represent the fold changes of luciferase activity, normalized to the renilla expression. Error bars represent SEM; p&lt;0.05 with Student’s t-test, of three independent experiments. All full data in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>In silico prediction of putative cellular nucleic acid-binding protein (CNBP) binding sites on the <italic>dOdc1</italic> mRNA by RBPmap.</title><p>The <italic>dOdc1</italic> transcript (FBtr0088863) was uploaded to the RBPmap web server for mapping binding sites. As criteria <italic>Drosophila</italic> genome, UGGAGNW consensus motif and high stringency level were used (<xref ref-type="bibr" rid="bib36">Paz et al., 2014</xref>; <ext-link ext-link-type="uri" xlink:href="http://rbpmap.technion.ac.il">http://rbpmap.technion.ac.il</ext-link>).</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-69269-fig6-figsupp2-data1-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Efficiency of dCNBP silencing.</title><p>Quantification by IMAGE J 1.50i of the levels of dCNBP in extracts (<bold>A</bold>) obtained from control larvae (<italic>no UAS</italic>) or from larvae where the <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> constructs (<italic>2XdCNBP<sup>RNAi</sup></italic>) are driven by the <italic>c179GAL4</italic> driver (from the immunoblot shown in <xref ref-type="fig" rid="fig6">Figure 6B</xref>); or in extracts (<bold>B</bold>) obtained from untreated S2 cells (<italic>CTRL</italic>) or from S2 cells CNBP-interfered (<italic>dCNBP<sup>RNAi</sup></italic>; from the immunoblot shown in <xref ref-type="fig" rid="fig6">Figure 6D</xref>). A.U., arbitrary unit. Quantification data in source data for western blot [WB] quantification.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>Cellular nucleic acid-binding protein (CNBP) promotes translation of <italic>dOdc</italic> mRNA.</title><p>Effect of <italic>human CNBP (hCNBP)</italic> depletion on both dOdc protein expression and mRNA level in 293T human cells. (<bold>A</bold>) Immunoblot showing a direct correlation of hCNBP depletion with a strong reduction of dOdc protein levels, with the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification). Actin, loading control. A.U., arbitrary unit. (B) <italic>dOdc1</italic> mRNA levels (qPCR), normalized with the GFP mRNA levels. Error bars represent SEM of three independent experiments; ns, not significant in unpaired t-test. Full data in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig6-figsupp4-v1.tif"/></fig></fig-group><p>In a previous report it was shown that mammalian CNBP regulates translation of several target mRNAs via an association with G-rich recognition elements (RRE), thereby resolving their G4 stable structures and promoting translational elongation (<xref ref-type="bibr" rid="bib5">Benhalevy et al., 2017</xref>). Interestingly, one of the targets identified in that study was the mRNA of ODC and our in silico analysis by RBPmap (<xref ref-type="bibr" rid="bib36">Paz et al., 2014</xref>; <ext-link ext-link-type="uri" xlink:href="http://rbpmap.technion.ac.il">http://rbpmap.technion.ac.il</ext-link>) predicted the presence of several UGGAGNW motifs (the most common RRE bound by hCNBP; <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>) in the <italic>Drosophila Odc1</italic> coding sequence. Thus, we tested if dCNBP regulates translational efficiency of <italic>dOdc1</italic> by binding its mature mRNA. To this end, we performed RNA immunoprecipitation (RIP) assay on S2 insect cell extracts and found that CNBP efficiently binds <italic>Odc</italic> mRNA (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, left). In addition, dCNBP was efficiently associated with dOdc mRNA in control (no UAS) but not in CNBP-deficient larval muscles (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, right). The RNAi efficiency was confirmed by western blotting (<xref ref-type="fig" rid="fig6">Figure 6B</xref> right and <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3A</xref>), demonstrating the specificity of the binding. Furthermore, in a heterologous system, after transfection of a vector expressing the <italic>dOdc1</italic> CDS, but lacking its UTRs, Odc protein synthesis was downregulated by CNBP depletion, while the mRNA levels remained unchanged (<xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>), thus supporting the hypothesis that dCNBP regulates <italic>dOdc</italic> mRNA translation by acting on its coding region.</p><p>To determine whether dCNBP influences translation of <italic>dOdc</italic> mRNA, we performed a sucrose fractionation of cytoplasmic lysates obtained from S2 cells in which <italic>dCNBP</italic> mRNA was knocked down or from control cells (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>). RNA was extracted from each fraction and analyzed by qRT-PCR (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). The RNAi efficiency was confirmed by western blotting (<xref ref-type="fig" rid="fig6">Figure 6D</xref> right and <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3B</xref>). In line with our assumption, in control lysates we found significant levels of <italic>dOdc</italic> mRNA in polysome fractions, the same where dCNBP was detected and co-purified with the ribosomal protein RpS6 (<xref ref-type="bibr" rid="bib1">Antonucci et al., 2014</xref>), indicating that Odc is actively translated. In contrast, the levels of <italic>dOdc</italic> mRNA were strongly reduced in the polysome fraction of dCNBP-deficient S2 cells, while they were significantly increased in the non-translating fractions (60–40S and free mRNA), demonstrating that dCNBP is required for <italic>dOdc</italic> mRNA loading into polysomes and therefore for its active translation (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>).</p></sec><sec id="s2-4"><title>Restoration of polyamine metabolism in dCNBP-deficient flies rescues locomotor phenotypes</title><p>To verify that the above-described mechanism leading to alteration of polyamine metabolism is truly responsible for the observed locomotor phenotype, we performed rescue experiments. We first fed <italic>dCNBP</italic> mutant or RNAi-expressing flies with putrescine dissolved into their food. As shown in <xref ref-type="fig" rid="fig7">Figure 7A and B</xref>, RNAi-expressing or <italic>dCNBP</italic> mutant larvae substantially recovered the locomotor defects after putrescine administration and, as expected, putrescine content significantly increased compared to controls reared on standard food (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). Similar data were obtained with spermidine (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). Then, we used the <italic>Mef2-GAL4</italic> or the <italic>c179-GAL4</italic> lines to drive simultaneous expression of <italic>UAS-dOdc1</italic> (<xref ref-type="bibr" rid="bib21">Gupta et al., 2013</xref>) and 2XUAS-<italic>dCNBP<sup>RNAi</sup>,</italic> and found that dOdc1 reconstitution significantly ameliorates the locomotor phenotype in <italic>dCNBP</italic>-depleted larvae (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The levels of the CNBP in these flies were very low and comparable to those observed in lines lacking only <italic>dCNBP</italic> (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3A</xref>). This indicates that the rescue of the locomotor defect can only be attributed to overexpression of <italic>dOdc1</italic>, and not to a potential dilution of the GAL4 driver.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Odc and polyamine are responsible for the CNBP-dependent locomotor phenotype.</title><p>(<bold>A–B</bold>) Rescue of locomotor phenotype in both <italic>dCNBP</italic>-depleted larvae (<bold>A</bold>) and <italic>dCNBP</italic> mutant larvae (<bold>B</bold>) by 1 mM putrescine feeding at 29°C. Box plot representation of the distribution of peristaltic contraction rates performed by the following genotypes: (<bold>A</bold>) c<italic>179GAL4</italic> driving <italic>no UAS</italic> or <italic>UAS-dCNBP<sup>RNAi-16283</sup>; UAS-dCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) with (1 mM put) or without (no put) putrescine. Note how putrescine feeding of interfered individuals results also in a higher stage of pupal development with respect to individuals not treated (photo in A). (<bold>B</bold>) Control (<italic>wild-type</italic>) or <italic>cnbp<sup>k</sup></italic> larvae with (1 mM put) or without (no put) putrescine. (****p&lt;0.0001; ns, not significant, Kruskal-Wallis with post hoc Dunn’s test). (<bold>C</bold>) Rescue of locomotor defects in <italic>dCNBP</italic>-depleted larvae by dOdc1 overexpression under the control of either <italic>Mef</italic>2 or <italic>c179GAL4</italic> driver. Box plot representation of the distribution of peristaltic contraction rates performed by the following genotypes: <italic>Mef2GAL4</italic> or <italic>c179GAL4</italic> (<italic>no UAS</italic>), <italic>Mef2GAL4</italic> or <italic>c179GAL4</italic>&gt;2X<italic>dCNBP<sup>RNAi</sup></italic>, <italic>Mef2GAL4</italic> or <italic>c179GAL4</italic>&gt;2X<italic>dCNBP<sup>RNAi</sup> + dOdc1</italic> (<italic>UASdCNBP<sup>RNAi-16283</sup>; Mef2GAL4/UASdCNBP<sup>RNAi-16284</sup>; UASdOdc1/TM6B</italic> or <italic>UASdCNBP<sup>RNAi-16283</sup>; c179GAL4/UASdCNBP<sup>RNAi-16284</sup></italic>; UAS d<italic>Odc1/+</italic>). (<bold>A–B–C</bold>) The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (****p&lt;0.0001; ns, not significant, Kruskal-Wallis with post hoc Dunn’s test); ≥10 larvae tested for each genotype in at least three independent experiments. (<bold>D</bold>) Mutants for <italic>dystrophin (Dys<sup>det-1</sup></italic>) present larval locomotor abnormalities that cannot b<italic>e</italic> rescued by feeding larvae with 1 mM putrescine. Box plot representation of the distribution of peristaltic contraction rates performed by <italic>Dys<sup>del-1</sup></italic> mutant larvae fed with or without putrescine (+1 mM put) with respect to <italic>wild-type</italic> control. The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (ns, not significant, ****p&lt;0.0001, Kruskal-Wallis with post hoc Dunn’s test); ≥10 larvae tested for each genotype in at least two independent experiments. All full data in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Larval and adult movement measurements as shown in <xref ref-type="fig" rid="fig7">Figure 7A-D</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref> and <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>. Putrescine content measurment as shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Effects of other polyamines on the cellular nucleic acid-binding protein (CNBP)-dependent locomotor phenotype.</title><p>(<bold>A</bold>) Columns represent the fold difference of putrescine content in dCNBP-depleted larvae grown in absence or presence of 1 mM putrescine. <italic>c179GAL4</italic> without putrescine (<italic>no UAS</italic>), <italic>c179GAL4</italic>&gt;<italic>UASdCNBP<sup>RNAi-16283</sup>; UASdCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) with (1 mM put) or without putrescine. **p&lt;0.01, ***p&lt;0.001 with t-test. (<bold>B</bold>) Box plot representation of the distribution of peristaltic contraction rates performed by third instar larvae of <italic>c179GAL4</italic> (<italic>no UAS</italic>) or by <italic>c179GAL4</italic>&gt;<italic>UASdCNBP<sup>RNAi-16283</sup>; UASdCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) with (1 mM spd) or without (no spd) spermidine. The line inside the box indicates the median for each genotype and box boundaries represent the first and third quartiles; whiskers are min and max in the 1.5 interquartile range (****p&lt;0.0001, ordinary one-way ANOVA post hoc Tukey’s test); ≥10 larvae tested for each genotype in at least two independent experiments. Error bars represent SEM. All full data in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>dOdc1 overexpression does not affect dCNBP downregulation.</title><p>Immunoblot showing the levels of dCNBP in control larvae (<italic>no UAS</italic>), compared to larvae interfered for <italic>dCNBP</italic> (<italic>UASdCNBP<sup>RNAi-16283</sup>; UASdCNBP<sup>RNAi-16284</sup></italic>; named 2X<italic>dCNBP<sup>RNAi</sup></italic>), or overexpressing <italic>dOdc1 (UAS-dOdc1)</italic>, or to larvae overexpressing <italic>dOdc1</italic> and simultaneously interfered for <italic>dCNBP</italic> (<italic>UASdCNBP<sup>RNAi-16283</sup>; Mef2-GAL4/UASdCNBP<sup>RNAi-16284</sup>; UAS Odc1/TM6B;</italic> named 2X<italic>dCNBP<sup>RNAi</sup>+dOdc1</italic>) under the control of the <italic>Mef2-GAL4</italic> driver. On the right, the corresponding band quantification normalized on the loading control (IMAGE J 1.50i; quantification data in source data for western blot [WB] quantification) is shown. Tubulin, loading control. A.U., arbitrary unit.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig7-figsupp2-v1.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title><italic>dCNBP</italic>-depleted flies exhibited an ageing-dependent locomotor dysfunction.</title><p><italic>mhcGAL4 (no UAS)</italic> or <italic>mhcGAL4 &gt; UASdCNBP<sup>RNAi-16283</sup>; UASdCNBP<sup>RNAi-16284</sup></italic> (2X<italic>UASdCNBP<sup>RNAi</sup></italic>) reared at 29°C, male flies were assayed for negative geotaxis measured by the <italic>Drosophila</italic> activity monitoring (DAM) system at the indicated ages (error bars represent SEM; ***p&lt;0.001; ****p&lt;0.0001, Kruskal-Wallis with post hoc Dunn’s test); ≥15 males tested for each genotype in at least two independent experiments. Full data in <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig7-figsupp3-v1.tif"/></fig><fig id="fig7s4" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 4.</label><caption><title>dCNBP depletion does not cause morphological changes of fly larval muscle tissues.</title><p>Muscle morphology and sarcomeric organization of the L2/L3 larval body wall muscles. Confocal images of larval muscles (segment A2; muscle 6/7) form <italic>wild-type (WT)</italic> controls, <italic>UASdCNBP<sup>RNAi-16283</sup>; UASdCNBP<sup>RNAi-16284</sup></italic> (2X<italic>dCNBP<sup>RNAi</sup></italic>) driven by either <italic>how<sup>24B</sup>GAL4</italic> or <italic>c179GAL4</italic> as indicated (third instar larvae) or from <italic>cnbp<sup>k</sup></italic> mutant (second instar larvae), stained with DAPI (green) and FITC phalloidin (red); ≥3 larvae have been tested for each genotype in at least two independent experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig7-figsupp4-v1.tif"/></fig></fig-group><p>Of note, we showed that feeding with 1 mM putrescine mutants for <italic>dystrophin (Dys<sup>det-1</sup></italic>), a fly model of Duchenne muscle dystrophy (DMD), did not recover the <italic>Dys-</italic>dependent larval locomotor abnormalities (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), indicating that the recovery of polyamine metabolism is specifically required for alleviating <italic>dCNBP</italic> loss-of-function locomotor defects.</p><p>It is known that polyamines decrease during aging in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib21">Gupta et al., 2013</xref>). Moreover, the decline of locomotor ability with age is common in many species of animals and muscular dystrophies gradually progress with age, along with increased muscle breakdown. Thus, we performed the DAM climbing assay with the <italic>dCNBP</italic> RNAi-expressing adults at different times after eclosion. We found that the <italic>dCNBP</italic>-depleted adults showed a faster ageing-dependent decline of climbing ability, as 15 days aged adult flies performed a significantly lower number of climbing events/30 min compared to wild-type control flies (<xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>). Thus, it could be speculated that dCNBP depletion accelerates ageing-dependent locomotor decline, similar to that observed in DM patients (<xref ref-type="bibr" rid="bib31">Mateos-Aierdi et al., 2015</xref>). This acceleration may well be a consequence of an ageing-dependent polyamines decrease (<xref ref-type="bibr" rid="bib21">Gupta et al., 2013</xref>). However, we cannot also exclude that the ageing-dependent acceleration of the locomotor dysfunction upon CNBP silencing could be linked to either developmental defects or to heterogeneous backgrounds. Further studies will be required to address these points.</p><p>Together, these results indicate that ODC and polyamine defects are responsible for the observed CNBP loss-of-function locomotor phenotype.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>It is widely recognized that DM1 and DM2 share many clinical features due to a common pathogenic mechanism, consisting in the toxic accumulation of RNA, resulting from the expansion of CTG triplets or CCTG quadruplets, respectively. However, the two diseases differ in some clinical manifestations, such as the preeminent involvement of proximal muscles in DM2 and of distal muscles in DM1. Therefore, it is possible that additional mechanisms contribute to the pathogenesis of the two diseases, by acting as disease modifiers. Indeed, the pathologies of repeat expansion-associated diseases are very complex, as both coding and non-coding repeat expansions may involve a combination of mechanisms, including protein loss-of-function, toxic RNA gain-of-function, and toxic protein gain-of-function.</p><p>In DM2, the quadruplet expansion occurs within the first intron of the <italic>CNBP</italic> gene and this has given rise to the hypothesis that this genetic alteration may cause splicing defects/protein sequestration, leading to reduced CNBP levels. However, while some studies reported that CNBP levels are significantly reduced in muscle of DM2 patients, other works failed to observe such a reduction (<xref ref-type="bibr" rid="bib17">Eisenberg et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Eisenberg et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Huichalaf et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Raheem et al., 2010</xref>; <xref ref-type="bibr" rid="bib42">Salisbury et al., 2009</xref>; <xref ref-type="bibr" rid="bib44">Schneider-Gold and Timchenko, 2010</xref>; <xref ref-type="bibr" rid="bib50">Wei et al., 2018</xref>), most likely as a consequence of the limited sample sizes and the variability of the disease. Therefore, whether CNBP reduction plays a pathogenic role in DM2 is still a debated issue.</p><p>Previous studies in mice demonstrated that both heterozygous and homozygous deletion of CNBP alleles causes relevant muscle defects (<xref ref-type="bibr" rid="bib9">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="bib50">Wei et al., 2018</xref>), suggesting a role of CNBP loss-of-function in the pathogenesis of the disease. In particular, while homozygous deletion of CNBP is associated to muscle atrophy and severe impairment of muscle performance at young age, the heterozygous CNBP KO mice show milder muscle dysfunctions, but develop a more pronounced locomotor phenotype at advanced age, reminiscent of DM2 disease (<xref ref-type="bibr" rid="bib50">Wei et al., 2018</xref>). This latter observation is consistent with the onset of clinical manifestations in DM2 patients, which typically begins in the elderly, after the age of 60.</p><p>In the present work we have addressed for the first time the specific role of CNBP in muscle, using <italic>D. melanogaster</italic> as a model. Using muscle-specific drivers, expressed at various stages of muscle development, we have ablated <italic>dCNBP</italic> gene from muscle tissues and observed severe locomotor defects that, in analogy with observations in patients and other animal models, become more pronounced with age.</p><p>CNBP deficiency is sufficient to cause this effect as evidenced by the finding that reconstitution with either dCNBP or hCNBP fully rescues the locomotor phenotype.</p><p>We have found that when <italic>dCNBP</italic> is knocked down at early stages of muscle development, very severe phenotypes or lethality ensue, and that knock down specifically in differentiated muscles results in robust locomotor defects. This suggests that CNBP is necessary to ensure not only proper muscle development, but also its function in the adult. Surprisingly, in contrast with studies in homozygous KO mice showing marked muscle atrophy, our morphological analysis of muscle tissues did not show significant changes upon CNBP knockdown (<xref ref-type="fig" rid="fig7s4">Figure 7—figure supplement 4</xref>). A plausible explanation for this discrepancy could be that the phenotype observed in mice is the result of the constitutive loss of CNBP in all tissues, while in our models the protein was deleted exclusively in muscle territories, likely affecting their function but not their architecture. We did not see clear differences in muscle morphology also in dCNBP mutant larvae compared to controls (<xref ref-type="fig" rid="fig7s4">Figure 7—figure supplement 4</xref>). However, dCNBP mutant animals die early during larval development (second instar), thus it is possible that such a short survival of dCNBP mutant larvae does not allow sufficient time for the muscle alterations to be fully developed and appreciated. Additionally, it cannot be excluded that an early requirement of dCNBP for muscle development might be overshadowed by the presence of maternal contribution provided by the heterozygous mother flies.</p><p>Mechanistically, we provide evidence that the observed phenotype is linked to the ability of CNBP to control polyamine content, by regulating ODC translation. In our previous studies, we found that in mammalian cells, CNBP binds to the 5’UTR of ODC mRNA, thereby regulating IRES-mediated translation and polyamine metabolism (<xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>). Indeed, mammalian ODC mRNA has a relatively long (about 350 nts) 5’UTR and its translation can be initiated at specific internal pyrimidine-rich sequences (<xref ref-type="bibr" rid="bib39">Pyronnet et al., 2000</xref>) that were also found to bind CNBP (<xref ref-type="bibr" rid="bib18">Gerbasi and Link, 2007</xref>). In contrast, the 5’UTR of dOdc measures only 27 nts, lacks the pyrimidine-rich sequences, and does not show any IRES activity after ectopic expression of CNBP. Therefore, dCNBP does not seem to regulate translation of dOdc through an IRES-mediated mechanism.</p><p>A previous work demonstrated that CNBP facilitates translational elongation in mammalian cells, by binding G-rich motifs and resolving stable secondary structures of a number of putative transcripts, being ODC mRNA among the targets identified in that screening, although not functionally validated (<xref ref-type="bibr" rid="bib5">Benhalevy et al., 2017</xref>). These observations suggest a dual mode of CNBP regulation of ODC translation in mammals, at the level of both internal initiation and elongation across G-rich sites.</p><p>In this work we found that dCNBP binds <italic>dOdc</italic> mRNA and regulates its translation, likely acting at the coding region, thus supporting the conclusion that CNBP promotes <italic>dOdc</italic> translational elongation through the same mechanism described in mammalian cells and suggesting that the regulation of ODC by CNBP is a very important and evolutionary conserved mechanism.</p><p>Of note, in this work we have demonstrated that the locomotor defects caused by CNBP deficiency are linked to a significant decrease of polyamine content and, importantly, that the defects can be rescued by restoring dOdc expression or by polyamine supplementation. This molecular mechanism seems to be specifically linked to CNBP loss-dependent muscle dysfunction, as polyamine supplementation was unable to ameliorate the locomotor defects in a fly model of DMD. Our own data obtained from a small cohort of DM2 patients support the hypothesis that the polyamine metabolism is also altered in human DM2 muscle tissues. However, due to the heterogeneity of this disease, a study specifically addressing the representation of CNBP and polyamines, measuring their content in various muscles, as well as investigating the molecular mechanisms leading to CNBP downregulation in a large number of patients is needed to establish more compelling evidence. Thus, whether DM2 patients may benefit from polyamine supplementation represents a crucial question opened by this work that deserves further investigation. Interestingly, previous work demonstrated that reduced polyamine content correlates with the severity of muscle dysfunction in a mouse model of another form of human muscle dystrophy: LAMA2-congenital muscle dystrophy (CMD; <xref ref-type="bibr" rid="bib27">Kemaladewi et al., 2018</xref>). Like DM2, CMD is characterized by phenotypic variability and differentially affects specific muscle groups, possibly as a consequence of a differential expression of polyamine regulators and polyamine content.</p><p>Therefore, it is possible that CNBP also acts as a disease modifier in DM2, causing the differential distribution of polyamine content among distal and proximal muscles, which in turn sustains the clinical heterogeneity of this disease.</p><p>How polyamines affect muscle function remains to be understood. A previous study reported that supplementation of both mice and <italic>Drosophila</italic> diet with spermidine extends their lifespan (<xref ref-type="bibr" rid="bib17">Eisenberg et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Eisenberg et al., 2009</xref>) and exerts protective effects on cardiac muscle of mice, by promoting cardiac autophagy, mitophagy, and mitochondrial respiration (<xref ref-type="bibr" rid="bib17">Eisenberg et al., 2016</xref>; <xref ref-type="bibr" rid="bib16">Eisenberg et al., 2009</xref>). Thus, it is possible that an impairment of these mechanisms in muscle may be involved in the observed phenotype of CNBP-deficient animals and possibly in DM2 patients. Moreover, polyamines are among the substances that have been reported to decline with age (<xref ref-type="bibr" rid="bib21">Gupta et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Liu et al., 2008</xref>) and the phenotype of CNBP-deficient animals or the clinical manifestation of DM2 patients is also correlated with the advanced age. Therefore, it is possible that polyamine may be involved, at least in part, in the ageing-dependent manifestations of the disease. Further studies on the role and mechanism of action of polyamines in muscle function are thus required to elucidate this critical issue.</p><p>In conclusion, we have identified an unprecedented mechanism whereby dCNBP controls muscle function by regulating the ODC/polyamine axis (<xref ref-type="fig" rid="fig8">Figure 8</xref>). This function of dCNBP we have described in <italic>Drosophila</italic> seems to be evolutionarily conserved in vertebrates, with relevant implications in DM2 disease.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Cellular nucleic acid-binding protein (CNBP) controls muscle function by regulating polyamine metabolism.</title><p>Schematic representation of the mechanism of action of CNBP on muscle function in both <italic>Drosophila</italic> and humans. CNBP binds ornithine decarboxylase (ODC) mRNA and regulates its translation, leading to increased polyamine content. Lack of CNBP impairs locomotor function through ODC-polyamine downregulation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69269-fig8-v1.tif"/></fig></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>actin-GAL4</italic></td><td>Bloomington</td><td>25374</td><td><italic>y[1] w[*]; P{Act5C-GAL4-w}E1/CyO</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>tubulin-GAL4</italic></td><td>Bloomington</td><td>5138</td><td><italic>y[1] w[*]; P{w[+mC]=tubP-GAL4}LL7/TM3, Sb[1] Ser[1]</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>elav-GAL4</italic></td><td>Bloomington</td><td>77894</td><td><italic>y[1] w[*] P{w[+mC]=elav(FRT.ewg)GAL4.eFeG}1</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>nrv-GAL4</italic></td><td>Bloomington</td><td>6799</td><td><italic>w[*]; P{w[+mC]=nrv2-GAL4.S}8</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>D42-GAL4</italic></td><td>Bloomington</td><td>8816</td><td><italic>w[*]; P{w[+mW.hs]=GawB}D42</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>n-syb-GAL4</italic></td><td>Bloomington</td><td>51635</td><td><italic>y[1] w[*]; P{w[+m*]=nSyb-GAL4.S}3</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>repo-GAL4</italic></td><td>Bloomington</td><td>7415</td><td><italic>w[1118]; P{w[+m*]=GAL4} repo/TM3, Sb[1]</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>69B-GAL4</italic></td><td>Bloomington</td><td>1744</td><td><italic>w[*]; P{w[+mW.hs]=GawB}69B</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>Mhc-GAL4</italic></td><td>Bloomington</td><td>38464</td><td>; w[*]; <italic>P{w[+mC]=Mhc-RFP.F3-580}</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>Mef2-GAL4</italic></td><td>Bloomington</td><td>26882</td><td><italic>w[*]; Kr[If-1]/CyO, P{w[+mC]=GAL4-Mef2.R}2, P{w[+mC]=UAS-mCD8.mRFP}</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>c179-GAL4</italic></td><td>Bloomington</td><td>6450</td><td><italic>w[*]; P{w[+mW.hs]=GawB}c179</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>how<sup>24B</sup>-GAL4</italic></td><td>Bloomington</td><td>1767</td><td><italic>w[*]; P{w[+mW.hs]=GawB}how[24B]</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>GMR-GAL4</italic></td><td>Bloomington</td><td>9146</td><td><italic>w[1118]; P{GMR-GAL4.w[-]}2/CyO</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>nub-GAL4</italic></td><td>Bloomington</td><td>86108</td><td><italic>w[*]; P{w[nub.PK]=nub-GAL4.K}2</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>5053</italic> GAL4</td><td>Bloomington</td><td>2702</td><td><italic>w[*]; P{w[+mW.hs]=GawB}tey[5053A]/TM6B, Tb[+]</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>srmd710-GAL4</italic></td><td>Bloomington</td><td>26663</td><td><italic>w[*]; P{w[+mW.hs]=GawB}sr[md710]/TM6B, Tb[1]</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS dCNBP<sup>RNAi</sup></italic></td><td>VDRC</td><td>GD16283</td><td>CNBP long hairpin on chromosome X</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS dCNBP<sup>RNAi</sup></italic></td><td>VDRC</td><td>GD16284</td><td>CNBP long hairpin on chromosome 2</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>2XUAS dCNBP<sup>RNAi</sup></italic></td><td><xref ref-type="bibr" rid="bib1">Antonucci et al., 2014</xref></td><td>GD16283+ GD16284</td><td>-</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>dCNBP <sup>k</sup></italic></td><td>Kyoto</td><td>203535</td><td><italic>y[1] w[67c23]; P{w[+mC]=GSV6}GS11716 / SM1</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS dCNBP-HA RNAi resistant</italic></td><td>This study</td><td>–</td><td>Injection stock #BL 8622</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS hCNBP-FLAG</italic></td><td>This study</td><td>–</td><td>Injection stock #BL 8622</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS Odc1<sup>RNAi</sup></italic></td><td>VDRC</td><td>GD30039</td><td>Odc1 long hairpin on chromosome 3</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS Odc1<sup>RNAi</sup></italic></td><td>VDRC</td><td>GD30038</td><td>Odc1 long hairpin on chromosome 2</td></tr><tr><td>Genetic reagent <break/>(<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS Odc2<sup>RNAi</sup></italic></td><td>VDRC</td><td>KK104597</td><td>Odc2 long hairpin on chromosome 2</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS Odc1+Odc2<sup>RNAi</sup></italic></td><td>This study</td><td>GD30038+ KK104597</td><td>Long hairpin for Odc2 on chromosome 2 and for Odc1 on chromosome 3</td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>dOdc1 mutant</italic></td><td>Bloomington</td><td>56103</td><td><italic>y[1] w[*]; Mi{y[+mDint2]=MIC}Odc1[MI10996]</italic></td></tr><tr><td>Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td><italic>UAS dOdc1</italic></td><td><xref ref-type="bibr" rid="bib21">Gupta et al., 2013</xref></td><td>-</td><td>-</td></tr><tr><td>Antibody</td><td>anti-CNBP <break/>(goat)</td><td>Abcam</td><td>ab48027, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB870003">AB870003</ext-link></td><td>WB 1:1000</td></tr><tr><td>Antibody</td><td>anti-ODC <break/>(rabbit)</td><td>ENZO</td><td>BML-PW8880-0100 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2156495">AB_2156495</ext-link></td><td>WB 1:500</td></tr><tr><td>Antibody</td><td>anti-Actin goat</td><td>Santa Cruz</td><td>sc-1616, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB630836">AB630836</ext-link></td><td>WB 1:3000</td></tr><tr><td>Antibody</td><td>anti-GFP <break/>(mouse)</td><td>Santa Cruz</td><td>sc-9996, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_627695">AB_627695</ext-link></td><td>WB 1:3000</td></tr><tr><td>Antibody</td><td>anti-Vinculin <break/>(mouse)</td><td>Santa Cruz</td><td>sc-73614, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1131294">AB_1131294</ext-link></td><td>WB 1:3000</td></tr><tr><td>Antibody</td><td>anti-FLAG-HRP</td><td>Sigma</td><td>A8592, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_439702">AB_439702</ext-link></td><td>WB 1:500</td></tr><tr><td>Antibody</td><td>anti-CNBP <break/>(mouse)</td><td>Agrobio <break/>(this study)</td><td>–</td><td>WB 1:1000</td></tr><tr><td>Antibody</td><td>anti-HA-HRP <break/>(mouse)</td><td>Santa Cruz</td><td>sc-7392, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_627809">AB_627809</ext-link></td><td>WB 1:2000</td></tr><tr><td>Antibody</td><td>anti-vibrator (rabbit)</td><td><xref ref-type="bibr" rid="bib19">Giansanti et al., 2006</xref></td><td>-</td><td>WB 1:3000</td></tr><tr><td>Sequence-based reagent</td><td><italic>T7 CNBP FW</italic> <break/><italic>Drosophila melanogaster</italic></td><td>This study</td><td>dsRNA primer</td><td>TAATACGACTCACTATAG<underline>GGAG GTCCGGGCGGCGTTGG</underline></td></tr><tr><td>Sequence-based reagent</td><td><italic>T7 CNBP RV</italic> <break/><italic>Drosophila melanogaster</italic></td><td>This study</td><td>dsRNA primer</td><td>TAATACGACTCACTATAG<underline>GGAG ATGTGTCCGGTGCGG</underline></td></tr><tr><td>Sequence-based reagent</td><td><italic>dOdc1 Fw</italic> <break/><italic>Drosophila melanogaster</italic></td><td>This study</td><td>PCR primer</td><td>TGGCAGCGATGACGTAAAGTT</td></tr><tr><td>Sequence-based reagent</td><td><italic>dOdc1 Rv</italic> <break/><italic>Drosophila melanogaster</italic></td><td>This study</td><td>PCR primer</td><td>TGGTTCGGCGATTATGTGAA</td></tr><tr><td>Sequence-based reagent</td><td><italic>GAPDH Fw</italic> <break/><italic>Drosophila melanogaster</italic></td><td>This study</td><td>PCR primer</td><td>CCTGGCCAAGGTCATCAATG</td></tr><tr><td>Sequence-based reagent</td><td><italic>GAPDH RvDrosophila melanogaster</italic></td><td>This study</td><td>PCR primer</td><td>ATGACCTTGCCCACAGCCTT</td></tr><tr><td>Sequence-based reagent</td><td>dOdc1-IRES FW</td><td>This study</td><td>PCR primer</td><td>TAAGAATTCCTCGGAAAGATCTCAAC</td></tr><tr><td>Sequence-based reagent</td><td>dOdc1-IRES RW</td><td>This study</td><td>PCR primer</td><td>TTAGAATTCACAAGTCGT TGACTGATAAC</td></tr><tr><td>Chemical compound, drug</td><td>DFMO</td><td>Sigma</td><td>#D193</td><td/></tr><tr><td>Commercial assay or kit</td><td>RevertAid H Minus First Strand cDNA Synthesis kit</td><td>Thermo Fisher Scientific</td><td>K1632</td><td/></tr><tr><td>Chemical compound, drug</td><td>Putrescine</td><td>Sigma</td><td>#51799</td><td/></tr><tr><td>Chemical compound, drug</td><td>Spermidine</td><td>Sigma</td><td>#S2626</td><td/></tr><tr><td>Plasmids</td><td>plko SCR, plkoSh_cnbp</td><td><xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref></td><td/><td/></tr><tr><td>Plasmids</td><td>GFP</td><td><xref ref-type="bibr" rid="bib12">Coni et al., 2020</xref></td><td/><td/></tr><tr><td>Plasmids</td><td>hODC-LUC</td><td><xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref></td><td/><td/></tr><tr><td>Plasmids</td><td>dOdc1-LUC</td><td>This study</td><td/><td/></tr><tr><td>Plasmids</td><td>HA-dCNBP</td><td><xref ref-type="bibr" rid="bib1">Antonucci et al., 2014</xref></td><td/><td/></tr><tr><td>Plasmids</td><td>FLAG-hCNBP</td><td><xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref></td><td/><td/></tr><tr><td>Cell line</td><td>S2</td><td>DGRC</td><td>Cat# 181, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_Z992">CVCL_Z992</ext-link></td><td/></tr><tr><td>Cell line</td><td>HEK-293T</td><td>ATCC</td><td>CRL-3216, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0063">CVCL_0063</ext-link></td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>Drosophila</italic> strains and rearing conditions</title><p><italic>Drosophila</italic> stocks were maintained on standard fly food (25 g/L corn flour, 5 g/L lyophilized agar, 50 g/L sugar, 50 g/L fresh yeast, 2,5 mL/L Tegosept [10% in ethanol], and 2.5 mL/L propionic acid) at 25°C in a 12 hr light/dark cycle. All experiments were performed in the same standard conditions, at the temperature reported in figure legends.</p><p>The <italic>2XUAS-dCNBP<sup>RNAi</sup></italic> strain used for <italic>dCNBP</italic> downregulation was already described in <xref ref-type="bibr" rid="bib1">Antonucci et al., 2014</xref>. Essentially, are transgenic flies carrying two different <italic>UAS-dCNBP</italic><sup>RNAi</sup> constructs (VDRC, ID 16283 and 16284) one on the X and one on the second chromosome, respectively.</p><p>The <italic>UAS-Odc1<sup>RNAi</sup></italic> and the <italic>UAS-Odc2<sup>RNAi</sup></italic> strains were also obtained from VDRC (ID 30039 and 104597) and similarly were combined to generate the strain <italic>UAS-dOdc1-2<sup>RNAi</sup></italic> bearing both constructs to downregulate both isoform at the same time. <italic>dCNBP<sup>k</sup></italic> is one of the P element insertions in the <italic>CG3800</italic> locus obtained from the Kyoto DGRC (#203535). The RNAi-resistant <italic>dCNBP</italic> gene carries synonymous substitutions in each residue of the region recognized by <italic>UAS-dCNBP<sup>RNAi</sup></italic> and was synthesized by Genewiz (Sigma-Aldrich). The plasmids for inducible expression of RNAi-resistant <italic>dCNBP-3HA</italic> (abbreviated with <italic>dCNBP-3HA-res</italic>) were generated by cloning the 3 HA epitope CDS fused in-frame with the 3′ end of the <italic>RNAi</italic>-resistant <italic>dCNBP</italic> CDS into the UAS-attB vector (Genewiz, Sigma-Aldrich). The plasmids for inducible expression of the <italic>hCNBP</italic> counterpart were generated by cloning the FLAG epitope CDS fused in-frame with the 3′ end of the <italic>hCNBP</italic> CDS (CNBP-201 splice variant, CCDS 3056.1) into the UAS-attB vector (Genewiz, Sigma-Aldrich). The <italic>dCNBP-3HA-res</italic> or <italic>UAS-hCNBP-FLAG</italic> were injected in y<sup>1</sup> w<sup>67c23</sup>; P{CaryP}attP2 embryos (BDSC Stock#8622); germline transformation was performed by Bestgene Inc (Chino Hills, CA) using standard procedures. <italic>UAS–Odc-1</italic> (<xref ref-type="bibr" rid="bib21">Gupta et al., 2013</xref>). All the driver lines used have been previously described and available from the Bloomington stock center.</p><p>Spermidine or putrescine was added to standard food to a final concentration of 1 mM. For experiments, parental flies mated on either normal or spd+ or put+ food, and their progeny was allowed to develop on the respective food. DFMO was added to normal food to a final concentration of 5 mM/day.</p></sec><sec id="s4-2"><title>Climbing assays</title><p>The locomotion activity was measured by the DAM system (TriKinetics Inc, Waltham, MA), which allows a measure of fly locomotion capabilities based on their negative geotactic response, as the number of climbing performances in 30 min; 10–15 ageing-synchronized male flies (2–3 days, 7 days, or 15 days of age) were gathered and placed in each monitor for each genotype for each experiment. Briefly, the DAM system (TriKinetics Inc) records activity from individual flies maintained in sealed tubes placed in activity monitors. An infrared beam directed through the midpoint of each tube measures an ‘activity event’ each time a fly crosses the beam. The number of climbing events was scored for 30 min, tapping flies to the bottom every 40 s. Events detected over the course of each consecutive sampling interval are summed and recorded over the course of 30 min for each fly.</p></sec><sec id="s4-3"><title><italic>Drosophila</italic> larval locomotion analyses</title><p>Larval locomotor activity was measured by counting the number of peristaltic contractions of third instar larvae performed within 1 min on the surface of a 1% agarose gel in a Petri dish; measurements were repeated five times for each larva, at least 10 larvae per genotype in each experiment.</p></sec><sec id="s4-4"><title>Immunoblot and antibodies</title><p>Protein extracts were derived from five third instar larvae, or cultured <italic>Drosophila</italic> S2 or human 293 cells, lysed in sample buffer, fractionated by SDS-PAGE and transferred to nitrocellulose membrane. Primary antibodies were: anti-CNBP goat (1:500; Abcam, Ab 48027); anti-Actin goat (1:1000; Santa Cruz, sc-1616); anti-ODC rabbit (1:500; Enzo Life Science, BML-PW8880-0100); anti-CNBP mouse (1:1000; generated by Agrobio for this work), anti-HA HRP (1:500; Santa Cruz, sc-7392), anti-GFP mouse (1:500; Santa Cruz, sc-9996); anti-FLAG HRP (1:1000; Sigma, A8592); anti-Vinculin mouse (1:1000; Santa Cruz, sc-73614); anti-Tubulin mouse (1:7000; Sigma, T-5168). As a secondary antibody, we used the appropriate HRP-conjugated antibody (GE Healthcare) diluted 1:5000 in 5% milk/PBS-Tween 0.1% (GE Healthcare). Detection was performed by using WesternBright ECL (K-12045-D50, Advansta). Bands densitometric analysis was performed using the ImageJ software (version 1.50i). For DM2 patient biopsies, samples were lysed in SDS urea (50 mM Tris-HCl pH 7.8; 2% SDS, 10% glycerol, 1 mM EDTA, 6 M urea, 50 mM NaF, 5 mM Na<sub>2</sub>P<sub>2</sub>O<sub>7</sub>) sonicated for 10 s, quantified by using a nanodrop and loaded on polyacrylamide gel. The study was carried out in line with the principles of the Declaration of Helsinki, and ethical approval was obtained from the Ethics Committee of the Fondazione Policlinico Universitario A Gemelli IRCCS Rome, Italy. Muscle biopsies used for this study were performed primarily for diagnostic purposes, after receiving an informed consent and consent to publish from all patients.</p></sec><sec id="s4-5"><title>RNA interference in S2 cell lines</title><p>S2 cells (DGRC, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_Z232">CVCL_Z232</ext-link>; tested negative for mycoplasma) were cultured at 25°C in Schneider’s insect medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco). RNAi treatments were carried out according to <xref ref-type="bibr" rid="bib45">Somma et al., 2008</xref>. dsRNA-treated cells were grown for 4–5 days at 25°C, and then processed for biochemical analyses. PCR products and dsRNAs were synthesized as described in <xref ref-type="bibr" rid="bib45">Somma et al., 2008</xref>. The primers used in the PCR reactions were 35 nt long and all contained a 5’ T7 RNA polymerase binding site (5’-<named-content content-type="sequence">TAATACGACTCACTATAGGGAGG</named-content>-3’) joined to a gene-specific sequence.</p></sec><sec id="s4-6"><title>RNA immunoprecipitation</title><p>S2 cells were plated in 75 cm<sup>2</sup> flask culture dishes and 72 hr later cells were crosslinked with 1% formaldehyde solution. Pellets were lysed with FA buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors, and 50 U/mL RNase inhibitor SupeRNase, #AM2694 Thermo Fisher Scientific) and sonicated.</p><p>For in vivo analysis, approximately 50 larval carcasses were UV-crosslinked (3 × 2000 µJ/cm<sup>2</sup>), homogenized on ice in 1 mL RCB buffer (50 mM HEPES pH 7.4, 200 mM NaCl, 2.5 mM MgCl<sub>2</sub>, 0.1% Triton X-100, 250 mM sucrose, 1 mM DTT, 1× EDTA-free Complete Protease Inhibitors, 1 mM PMSF), supplemented with 300 U RNAseOUT (Invitrogen), and placed on ice for 30 min. The homogenate was sonicated on ice, at 80% power, five times in 20 s bursts with a 60 s rest in between using the Hielscher Ultrasonic Processor UP100H (100 W, 30 kHz) and centrifuged (16,000× <italic>g</italic> for 5 min at 4°C).</p><p>Immunoprecipitation was performed by incubating the samples with anti-CNBP antibody or IgG overnight. Then, the samples were washed with RCB buffer four times, or with three different solutions for S2 extracts: low salt solution: 0.1% SDS, 1% Triton X-100 2 mM, EDTA 20 mM Tris-HCl pH 8, 150 mM NaCl, and 0.005 U/mL SuperRNAse (Thermo Fisher Scientific); high salt solution: 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8, 500 mM NaCl, and 0.005 U/mL SuperRNAse; LiCl buffer solution: 0.25 M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8, and 0.005 U/mL SuperRNAse; TE wash buffer solution: 10 mM Tris-HCl pH 8, 1 mM EDTA, and 0.005 U/mL SuperRNAse, and then eluted with H<sub>2</sub>O or elution buffer solution for S2 extracts: 1% SDS, 0.1 M NaHCO<sub>3</sub>, SuperRNase 50 U/mL. RNA was purified using Trizol reagent (15596026, Thermo Fisher Scientific), it was reverse-transcribed and dOdc was amplified by qPCR. Results were normalized on RPL11.</p></sec><sec id="s4-7"><title>RNA extraction and quantitative PCR</title><p>Total mRNA was isolated from S2 cells or <italic>Drosophila</italic> larvae by using Trizol reagent (15596026, Thermo Fisher Scientific) according to the manufacturer’s instructions. RNA was reverse-transcribed (1 µg each experimental point) by using SensiFAST cDNA Synthesis Kit (BIO-65053, Bioline) and qPCR was performed as described (<xref ref-type="bibr" rid="bib15">Di Magno et al., 2020</xref>) using SensiFast Sybr Lo-Rox Mix (BIO-94020, Bioline). The run was performed by using the Applied Biosystems (Waltham, MA) ViiA 7 Real-Time PCR System 36 instrument.</p><p>The following primers were used:</p><list list-type="simple"><list-item><p>dOdc1 Fw: <named-content content-type="sequence">TGGCAGCGATGACGTAAAGTT</named-content>;</p></list-item><list-item><p>dOdc1 Rv: <named-content content-type="sequence">TGGTTCGGCGATTATGTGAA</named-content>;</p></list-item><list-item><p>dRPL11 Fw; <named-content content-type="sequence">CCATCGGTATCTATGGTCTGGA</named-content>;</p></list-item><list-item><p>dRPL 11 Rv; <named-content content-type="sequence">CATCGTATTTCTGCTGGAACCA</named-content>;</p></list-item><list-item><p>GFP Fw: <named-content content-type="sequence">GCAAAGACCCCAACGAGAAG</named-content>;</p></list-item><list-item><p>GFP Rv: <named-content content-type="sequence">TTCTGATAGGCAGCCTGCAC</named-content>;</p></list-item><list-item><p>dGADPH Fw: <named-content content-type="sequence">CCTGGCCAAGGTCATCAATG</named-content>;</p></list-item><list-item><p>dGADPH Rv: <named-content content-type="sequence">ATGACCTTGCCCACAGCCTT</named-content>;</p></list-item></list></sec><sec id="s4-8"><title>Polysome analysis</title><p>Polysomal fractionation from S2 cells was performed as described previously (<xref ref-type="bibr" rid="bib12">Coni et al., 2020</xref>); S2 cells (interfered or not) were incubated 5 min with 100 μg/mL CHX, then washed with PBS and lysed with TNM buffer (10 mM Tris-HCl pH 7.4 or 7.5, 10 mM NaCl, 10 mM MgCl2, 1% Triton X-100), supplemented with 10 mM dithiothreitol, 100 μg/mL CHX, 1× PIC (1187358001 complete, EDTA free, Roche), and RiboLock RNase inhibitor (EO0382, Thermo Fisher Scientific). Lysates were incubated on ice for 10 min and then centrifuged at 2000 rpm for 5 min. Supernatants were loaded onto 15–50% sucrose gradients and centrifuged for 120 min in a Beckman SW41 rotor at 37,000 rpm at 4°C. Fractions were automatically collected, using Biorad-BioLogic LP/2110 (Hercules) monitoring the optical density at 260 nm. RNA was extracted from each fraction by using Trizol Reagent and dOdc mRNA was amplified by RT-qPCR. GAPDH mRNA was used for normalization.</p></sec><sec id="s4-9"><title>293T lentiviral transduction and transfection</title><p>Lentivirus production was performed as described in <xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>. Then human 293T cells were transduced with lentiviral particles of plkoSCR (Mission plko.1 puro; SHC002) or shCNBP human (Mission plko.1 puro TRCN0000311158, Sigma-Aldrich) at an MOI=5 for 72 hr. Then 293T cells SCR and shCNBP were transfected with plasmids encoding for dOdc and GFP for extra 24 hr, by using Dreamfect reagent according to manufacturer (DF41000 OZ, Biosciences). Cell extracts were analyzed through western blot and qPCR as indicated.</p></sec><sec id="s4-10"><title>Polyamine analysis</title><p>Polyamine content was determined by gas chromatography-mass spectrometry (GC-MS) and the values were normalized by the protein concentration. A pool of 10 third instar larvae for each genotype were resuspended in 0.2 M HClO and homogenized in an ice-bath using an ultra-turrax T8 blender. The homogenized tissue was centrifuged at 13,000× <italic>g</italic> for 15 min at 4°C; 0.5 mL of supernatant was spiked with internal standard 1,6-diaminohexane and adjusted to pH≥12 with 0.5 mL of 5 M NaOH. The samples were then subjected to sequential <italic>N</italic>-ethoxycarbonylation and <italic>N</italic>-pentafluoropropionylation. For DM2 samples, biopsies were also resuspended in 0.2 M HClO<sub>4</sub> and processed as described above. GC-MS analyses were performed with an Agilent 6850A gas chromatograph coupled to a 5973N quadrupole mass selective detector (Agilent Technologies, Palo Alto, CA). Chromatographic separations were carried out with an Agilent HP-5ms fused-silica capillary column. Mass spectrometric analysis was performed simultaneously in TIC (mass range scan from <italic>m/z</italic> 50 to 800 at a rate of 0.42 scans s–1) and SIM mode (put, <italic>m/z</italic> 405; spd, <italic>m/z</italic> 580, <italic>N</italic>1-acetyl-spm, <italic>m/z</italic> 637; spm, <italic>m/z</italic> 709).</p></sec><sec id="s4-11"><title>Immunostaining and confocal imaging</title><p>Larvae were dissected in ice-cold Ca<sup>2+</sup>-free HL3 saline and fixed in 4% formaldehyde for 10 min and washed in PBS containing 0.05% Triton X-100 (PBST) for 30 min. After washing, larval fillets were stained with phalloidin-TRITC (1:300 diluted in PBST, Sigma) for 40 min at room temperature and subsequently washed for 3× 20 min with 0.05% PBST. Larvae were mounted in Vectashield containing DAPI (Vector Laboratories).</p><p>Confocal microscopy was performed with a Leica SP8 confocal microscope (Leica Microsystems, Germany). Confocal imaging of larval fillets was done using a z step of 0.5 μm. The following objective was used: 63× 1.4 NA oil immersion for confocal imaging. All confocal images were acquired using the LCS AF software (Leica, Germany). Images from fixed samples were taken from third instar larval fillets (segment A2, muscle 6/7).</p></sec><sec id="s4-12"><title>Luciferase assays</title><p>For luciferase assays, 293T cells were seeded and transfected for 24 hr by using Dreamfect Reagent (DF45000, OZ Bioscience) with the dOdc or human ODC (hODC) luciferase-renilla bicistronic reporters, HA-dCNBP or FLAG-hCNBP expression vectors, or pcDNA3 as an empty vector. Luciferase reporter assay was performed by using the Firefly and Renilla Luciferase Single Tube Assay Kit (#30081–1, Biotium). Relative luciferase activity is expressed as the ratio of luciferase and renilla activity. The cloning of dOdc1 IRES was performed by PCR amplification of DNA from third instar larvae, by using the following oligos FW: <named-content content-type="sequence">TAAGAATTCCTCGGAAAGATCTCAAC</named-content>, RW: <named-content content-type="sequence">TTAGAATTCACAAGTCGT</named-content> <named-content content-type="sequence">TGACTGATAAC</named-content>. The amplicon was cloned in the backbone plasmid prl-Sammons (<xref ref-type="bibr" rid="bib13">D'Amico et al., 2015</xref>). The cloning product was checked on agarose gel after enzymatic restriction with the EcoR1 enzyme and the final plasmid was verified by sequencing.</p></sec><sec id="s4-13"><title>Statistical analyses</title><p>Statistical analysis was performed using Prism six software (MacKiev). The Shapiro-Wilk test was used to assess the normal distribution of every group of different genotypes. Statistical differences for multiple comparisons were analyzed with the Kruskal-Wallis for non-parametric values or with one-way ANOVA for parametric values. The Dunn’s or the Tukey’s test was performed, respectively, as post hoc test to determine the significance between every single group. The Mann-Whitney U-test or the t-test were used for two groups’ comparison of non-parametric or parametric values, respectively. A p&lt; 0.01 was considered significant.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by AFM Telethon (French Muscular Dystrophy Association, project 21025). AIRC (Associazione Italiana Ricerca Cancro IG 17575), Sapienza University grant RM1181642798C54A and Italian Ministry of Education, Universities and Research, Dipartimenti di Eccellenza-L (232/2016), Istituto Pasteur, Fondazione Cenci-Bolognetti, Rome Italy. We thank Vittorio Padovano for his contribution in generating the mouse anti-dCNBP antibody. We thank Gianluca Cestra for critical reading of the manuscript.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Supervision, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Supervision, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Supervision, Investigation, Methodology</p></fn><fn fn-type="con" id="con12"><p>Investigation</p></fn><fn fn-type="con" id="con13"><p>Supervision, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Human subjects: The study was carried out in line with the principles of the Declaration of Helsinki, and ethical approval was obtained from the Ethics Committee of the Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, Italy. Muscle biopsies used for this study were performed primarily for diagnostic purposes, after receiving an informed consent and consent to publish from all patients.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Original Blots for all Western Blot experiments.</title></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-69269-data1-v1.pptx"/></supplementary-material><supplementary-material id="sdata2"><label>Source data 2.</label><caption><title>Single Original Blots for all Western Blot experiments in tiff format.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-69269-data2-v1.zip"/></supplementary-material><supplementary-material id="sdata3"><label>Source data 3.</label><caption><title>Western Blot quantifications as shown in <xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, <xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>, <xref ref-type="fig" rid="fig6s4">Figure 1—figure supplement 4A</xref>, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69269-data3-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69269-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonucci</surname> <given-names>L</given-names></name><name><surname>D'Amico</surname> <given-names>D</given-names></name><name><surname>Di Magno</surname> <given-names>L</given-names></name><name><surname>Coni</surname> <given-names>S</given-names></name><name><surname>Di Marcotullio</surname> <given-names>L</given-names></name><name><surname>Cardinali</surname> <given-names>B</given-names></name><name><surname>Gulino</surname> <given-names>A</given-names></name><name><surname>Ciapponi</surname> <given-names>L</given-names></name><name><surname>Canettieri</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CNBP regulates wing development in <italic>Drosophila melanogaster</italic> by promoting IRES-dependent translation of dMyc</article-title><source>Cell Cycle</source><volume>13</volume><fpage>434</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.4161/cc.27268</pub-id><pub-id pub-id-type="pmid">24275942</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armas</surname> <given-names>P</given-names></name><name><surname>Nasif</surname> <given-names>S</given-names></name><name><surname>Calcaterra</surname> <given-names>NB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cellular nucleic acid binding protein binds G-rich single-stranded nucleic acids and may function as a nucleic acid chaperone</article-title><source>Journal of Cellular Biochemistry</source><volume>103</volume><fpage>1013</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1002/jcb.21474</pub-id><pub-id pub-id-type="pmid">17661353</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Caulfield</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Dejesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>van Blitterswijk</surname> <given-names>MM</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Paul</surname> <given-names>JW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS</article-title><source>Neuron</source><volume>77</volume><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.004</pub-id><pub-id pub-id-type="pmid">23415312</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bañez-Coronel</surname> <given-names>M</given-names></name><name><surname>Ayhan</surname> <given-names>F</given-names></name><name><surname>Tarabochia</surname> <given-names>AD</given-names></name><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Perez</surname> <given-names>BA</given-names></name><name><surname>Tusi</surname> <given-names>SK</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Borchelt</surname> <given-names>DR</given-names></name><name><surname>Ross</surname> <given-names>CA</given-names></name><name><surname>Margolis</surname> <given-names>RL</given-names></name><name><surname>Yachnis</surname> <given-names>AT</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Ranum</surname> <given-names>LP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RAN translation in Huntington disease</article-title><source>Neuron</source><volume>88</volume><fpage>667</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.038</pub-id><pub-id pub-id-type="pmid">26590344</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benhalevy</surname> <given-names>D</given-names></name><name><surname>Gupta</surname> <given-names>SK</given-names></name><name><surname>Danan</surname> <given-names>CH</given-names></name><name><surname>Ghosal</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>HW</given-names></name><name><surname>Kazemier</surname> <given-names>HG</given-names></name><name><surname>Paeschke</surname> <given-names>K</given-names></name><name><surname>Hafner</surname> <given-names>M</given-names></name><name><surname>Juranek</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The human CCHC-type zinc finger nucleic Acid-Binding protein binds G-Rich elements in target mRNA coding sequences and promotes translation</article-title><source>Cell Reports</source><volume>18</volume><fpage>2979</fpage><lpage>2990</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.080</pub-id><pub-id pub-id-type="pmid">28329689</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname> <given-names>JD</given-names></name><name><surname>McCurrach</surname> <given-names>ME</given-names></name><name><surname>Harley</surname> <given-names>HG</given-names></name><name><surname>Buckler</surname> <given-names>AJ</given-names></name><name><surname>Church</surname> <given-names>D</given-names></name><name><surname>Aburatani</surname> <given-names>H</given-names></name><name><surname>Hunter</surname> <given-names>K</given-names></name><name><surname>Stanton</surname> <given-names>VP</given-names></name><name><surname>Thirion</surname> <given-names>J-P</given-names></name><name><surname>Hudson</surname> <given-names>T</given-names></name><name><surname>Sohn</surname> <given-names>R</given-names></name><name><surname>Zemelman</surname> <given-names>B</given-names></name><name><surname>Snell</surname> <given-names>RG</given-names></name><name><surname>Rundle</surname> <given-names>SA</given-names></name><name><surname>Crow</surname> <given-names>S</given-names></name><name><surname>Davies</surname> <given-names>J</given-names></name><name><surname>Shelbourne</surname> <given-names>P</given-names></name><name><surname>Buxton</surname> <given-names>J</given-names></name><name><surname>Jones</surname> <given-names>C</given-names></name><name><surname>Juvonen</surname> <given-names>V</given-names></name><name><surname>Johnson</surname> <given-names>K</given-names></name><name><surname>Harper</surname> <given-names>PS</given-names></name><name><surname>Shaw</surname> <given-names>DJ</given-names></name><name><surname>Housman</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member</article-title><source>Cell</source><volume>68</volume><fpage>799</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90154-5</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calcaterra</surname> <given-names>NB</given-names></name><name><surname>Armas</surname> <given-names>P</given-names></name><name><surname>Weiner</surname> <given-names>AM</given-names></name><name><surname>Borgognone</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CNBP: a multifunctional nucleic acid chaperone involved in cell death and proliferation control</article-title><source>IUBMB Life</source><volume>62</volume><fpage>707</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1002/iub.379</pub-id><pub-id pub-id-type="pmid">20960530</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casero</surname> <given-names>RA</given-names></name><name><surname>Murray Stewart</surname> <given-names>T</given-names></name><name><surname>Pegg</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Polyamine metabolism and Cancer: treatments, challenges and opportunities</article-title><source>Nature Reviews Cancer</source><volume>18</volume><fpage>681</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1038/s41568-018-0050-3</pub-id><pub-id pub-id-type="pmid">30181570</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Abe</surname> <given-names>Y</given-names></name><name><surname>Cheney</surname> <given-names>L</given-names></name><name><surname>Udd</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>YP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy</article-title><source>Journal of Molecular Biology</source><volume>368</volume><fpage>8</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.01.088</pub-id><pub-id pub-id-type="pmid">17335846</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>DH</given-names></name><name><surname>Thienes</surname> <given-names>CP</given-names></name><name><surname>Mahoney</surname> <given-names>SE</given-names></name><name><surname>Analau</surname> <given-names>E</given-names></name><name><surname>Filippova</surname> <given-names>GN</given-names></name><name><surname>Tapscott</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Antisense Transcription and Heterochromatin at the DM1 CTG Repeats Are Constrained by CTCF</article-title><source>Molecular Cell</source><volume>20</volume><fpage>483</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.09.002</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coni</surname> <given-names>S</given-names></name><name><surname>Di Magno</surname> <given-names>L</given-names></name><name><surname>Serrao</surname> <given-names>SM</given-names></name><name><surname>Kanamori</surname> <given-names>Y</given-names></name><name><surname>Agostinelli</surname> <given-names>E</given-names></name><name><surname>Canettieri</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Polyamine metabolism as a therapeutic target in Hedgehog-Driven Basal Cell Carcinoma and Medulloblastoma</article-title><source>Cells</source><volume>8</volume><elocation-id>150</elocation-id><pub-id pub-id-type="doi">10.3390/cells8020150</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coni</surname> <given-names>S</given-names></name><name><surname>Serrao</surname> <given-names>SM</given-names></name><name><surname>Yurtsever</surname> <given-names>ZN</given-names></name><name><surname>Di Magno</surname> <given-names>L</given-names></name><name><surname>Bordone</surname> <given-names>R</given-names></name><name><surname>Bertani</surname> <given-names>C</given-names></name><name><surname>Licursi</surname> <given-names>V</given-names></name><name><surname>Ianniello</surname> <given-names>Z</given-names></name><name><surname>Infante</surname> <given-names>P</given-names></name><name><surname>Moretti</surname> <given-names>M</given-names></name><name><surname>Petroni</surname> <given-names>M</given-names></name><name><surname>Guerrieri</surname> <given-names>F</given-names></name><name><surname>Fatica</surname> <given-names>A</given-names></name><name><surname>Macone</surname> <given-names>A</given-names></name><name><surname>De Smaele</surname> <given-names>E</given-names></name><name><surname>Di Marcotullio</surname> <given-names>L</given-names></name><name><surname>Giannini</surname> <given-names>G</given-names></name><name><surname>Maroder</surname> <given-names>M</given-names></name><name><surname>Agostinelli</surname> <given-names>E</given-names></name><name><surname>Canettieri</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation</article-title><source>Cell Death &amp; Disease</source><volume>11</volume><elocation-id>1045</elocation-id><pub-id pub-id-type="doi">10.1038/s41419-020-03174-6</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Amico</surname> <given-names>D</given-names></name><name><surname>Antonucci</surname> <given-names>L</given-names></name><name><surname>Di Magno</surname> <given-names>L</given-names></name><name><surname>Coni</surname> <given-names>S</given-names></name><name><surname>Sdruscia</surname> <given-names>G</given-names></name><name><surname>Macone</surname> <given-names>A</given-names></name><name><surname>Miele</surname> <given-names>E</given-names></name><name><surname>Infante</surname> <given-names>P</given-names></name><name><surname>Di Marcotullio</surname> <given-names>L</given-names></name><name><surname>De Smaele</surname> <given-names>E</given-names></name><name><surname>Ferretti</surname> <given-names>E</given-names></name><name><surname>Ciapponi</surname> <given-names>L</given-names></name><name><surname>Giangaspero</surname> <given-names>F</given-names></name><name><surname>Yates</surname> <given-names>JR</given-names></name><name><surname>Agostinelli</surname> <given-names>E</given-names></name><name><surname>Cardinali</surname> <given-names>B</given-names></name><name><surname>Screpanti</surname> <given-names>I</given-names></name><name><surname>Gulino</surname> <given-names>A</given-names></name><name><surname>Canettieri</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Non-canonical hedgehog/AMPK-Mediated control of polyamine metabolism supports neuronal and medulloblastoma cell growth</article-title><source>Developmental Cell</source><volume>35</volume><fpage>21</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.09.008</pub-id><pub-id pub-id-type="pmid">26460945</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>AP</given-names></name><name><surname>Pipier</surname> <given-names>A</given-names></name><name><surname>Pascutti</surname> <given-names>F</given-names></name><name><surname>Binolfi</surname> <given-names>A</given-names></name><name><surname>Weiner</surname> <given-names>AMJ</given-names></name><name><surname>Challier</surname> <given-names>E</given-names></name><name><surname>Heckel</surname> <given-names>S</given-names></name><name><surname>Calsou</surname> <given-names>P</given-names></name><name><surname>Gomez</surname> <given-names>D</given-names></name><name><surname>Calcaterra</surname> <given-names>NB</given-names></name><name><surname>Armas</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CNBP controls transcription by unfolding DNA G-quadruplex structures</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>7901</fpage><lpage>7913</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz527</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Magno</surname> <given-names>L</given-names></name><name><surname>Manni</surname> <given-names>S</given-names></name><name><surname>Di Pastena</surname> <given-names>F</given-names></name><name><surname>Coni</surname> <given-names>S</given-names></name><name><surname>Macone</surname> <given-names>A</given-names></name><name><surname>Cairoli</surname> <given-names>S</given-names></name><name><surname>Sambucci</surname> <given-names>M</given-names></name><name><surname>Infante</surname> <given-names>P</given-names></name><name><surname>Moretti</surname> <given-names>M</given-names></name><name><surname>Petroni</surname> <given-names>M</given-names></name><name><surname>Nicoletti</surname> <given-names>C</given-names></name><name><surname>Capalbo</surname> <given-names>C</given-names></name><name><surname>De Smaele</surname> <given-names>E</given-names></name><name><surname>Di Marcotullio</surname> <given-names>L</given-names></name><name><surname>Giannini</surname> <given-names>G</given-names></name><name><surname>Battistini</surname> <given-names>L</given-names></name><name><surname>Goffredo</surname> <given-names>BM</given-names></name><name><surname>Iorio</surname> <given-names>E</given-names></name><name><surname>Agostinelli</surname> <given-names>E</given-names></name><name><surname>Maroder</surname> <given-names>M</given-names></name><name><surname>Canettieri</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phenformin inhibits Hedgehog-Dependent tumor growth through a complex I-Independent redox/Corepressor module</article-title><source>Cell Reports</source><volume>30</volume><fpage>1735</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.01.024</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname> <given-names>T</given-names></name><name><surname>Knauer</surname> <given-names>H</given-names></name><name><surname>Schauer</surname> <given-names>A</given-names></name><name><surname>Büttner</surname> <given-names>S</given-names></name><name><surname>Ruckenstuhl</surname> <given-names>C</given-names></name><name><surname>Carmona-Gutierrez</surname> <given-names>D</given-names></name><name><surname>Ring</surname> <given-names>J</given-names></name><name><surname>Schroeder</surname> <given-names>S</given-names></name><name><surname>Magnes</surname> <given-names>C</given-names></name><name><surname>Antonacci</surname> <given-names>L</given-names></name><name><surname>Fussi</surname> <given-names>H</given-names></name><name><surname>Deszcz</surname> <given-names>L</given-names></name><name><surname>Hartl</surname> <given-names>R</given-names></name><name><surname>Schraml</surname> <given-names>E</given-names></name><name><surname>Criollo</surname> <given-names>A</given-names></name><name><surname>Megalou</surname> <given-names>E</given-names></name><name><surname>Weiskopf</surname> <given-names>D</given-names></name><name><surname>Laun</surname> <given-names>P</given-names></name><name><surname>Heeren</surname> <given-names>G</given-names></name><name><surname>Breitenbach</surname> <given-names>M</given-names></name><name><surname>Grubeck-Loebenstein</surname> <given-names>B</given-names></name><name><surname>Herker</surname> <given-names>E</given-names></name><name><surname>Fahrenkrog</surname> <given-names>B</given-names></name><name><surname>Fröhlich</surname> <given-names>KU</given-names></name><name><surname>Sinner</surname> <given-names>F</given-names></name><name><surname>Tavernarakis</surname> <given-names>N</given-names></name><name><surname>Minois</surname> <given-names>N</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Madeo</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Induction of autophagy by spermidine promotes longevity</article-title><source>Nature Cell Biology</source><volume>11</volume><fpage>1305</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1038/ncb1975</pub-id><pub-id pub-id-type="pmid">19801973</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname> <given-names>T</given-names></name><name><surname>Abdellatif</surname> <given-names>M</given-names></name><name><surname>Schroeder</surname> <given-names>S</given-names></name><name><surname>Primessnig</surname> <given-names>U</given-names></name><name><surname>Stekovic</surname> <given-names>S</given-names></name><name><surname>Pendl</surname> <given-names>T</given-names></name><name><surname>Harger</surname> <given-names>A</given-names></name><name><surname>Schipke</surname> <given-names>J</given-names></name><name><surname>Zimmermann</surname> <given-names>A</given-names></name><name><surname>Schmidt</surname> <given-names>A</given-names></name><name><surname>Tong</surname> <given-names>M</given-names></name><name><surname>Ruckenstuhl</surname> <given-names>C</given-names></name><name><surname>Dammbrueck</surname> <given-names>C</given-names></name><name><surname>Gross</surname> <given-names>AS</given-names></name><name><surname>Herbst</surname> <given-names>V</given-names></name><name><surname>Magnes</surname> <given-names>C</given-names></name><name><surname>Trausinger</surname> <given-names>G</given-names></name><name><surname>Narath</surname> <given-names>S</given-names></name><name><surname>Meinitzer</surname> <given-names>A</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Kirsch</surname> <given-names>A</given-names></name><name><surname>Eller</surname> <given-names>K</given-names></name><name><surname>Carmona-Gutierrez</surname> <given-names>D</given-names></name><name><surname>Büttner</surname> <given-names>S</given-names></name><name><surname>Pietrocola</surname> <given-names>F</given-names></name><name><surname>Knittelfelder</surname> <given-names>O</given-names></name><name><surname>Schrepfer</surname> <given-names>E</given-names></name><name><surname>Rockenfeller</surname> <given-names>P</given-names></name><name><surname>Simonini</surname> <given-names>C</given-names></name><name><surname>Rahn</surname> <given-names>A</given-names></name><name><surname>Horsch</surname> <given-names>M</given-names></name><name><surname>Moreth</surname> <given-names>K</given-names></name><name><surname>Beckers</surname> <given-names>J</given-names></name><name><surname>Fuchs</surname> <given-names>H</given-names></name><name><surname>Gailus-Durner</surname> <given-names>V</given-names></name><name><surname>Neff</surname> <given-names>F</given-names></name><name><surname>Janik</surname> <given-names>D</given-names></name><name><surname>Rathkolb</surname> <given-names>B</given-names></name><name><surname>Rozman</surname> <given-names>J</given-names></name><name><surname>de Angelis</surname> <given-names>MH</given-names></name><name><surname>Moustafa</surname> <given-names>T</given-names></name><name><surname>Haemmerle</surname> <given-names>G</given-names></name><name><surname>Mayr</surname> <given-names>M</given-names></name><name><surname>Willeit</surname> <given-names>P</given-names></name><name><surname>von Frieling-Salewsky</surname> <given-names>M</given-names></name><name><surname>Pieske</surname> <given-names>B</given-names></name><name><surname>Scorrano</surname> <given-names>L</given-names></name><name><surname>Pieber</surname> <given-names>T</given-names></name><name><surname>Pechlaner</surname> <given-names>R</given-names></name><name><surname>Willeit</surname> <given-names>J</given-names></name><name><surname>Sigrist</surname> <given-names>SJ</given-names></name><name><surname>Linke</surname> <given-names>WA</given-names></name><name><surname>Mühlfeld</surname> <given-names>C</given-names></name><name><surname>Sadoshima</surname> <given-names>J</given-names></name><name><surname>Dengjel</surname> <given-names>J</given-names></name><name><surname>Kiechl</surname> <given-names>S</given-names></name><name><surname>Kroemer</surname> <given-names>G</given-names></name><name><surname>Sedej</surname> <given-names>S</given-names></name><name><surname>Madeo</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cardioprotection and lifespan extension by the natural polyamine spermidine</article-title><source>Nature Medicine</source><volume>22</volume><fpage>1428</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1038/nm.4222</pub-id><pub-id pub-id-type="pmid">27841876</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerbasi</surname> <given-names>VR</given-names></name><name><surname>Link</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The Myotonic Dystrophy Type 2 Protein ZNF9 Is Part of an ITAF Complex That Promotes Cap-independent Translation</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>6</volume><fpage>1049</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1074/mcp.M600384-MCP200</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giansanti</surname> <given-names>MG</given-names></name><name><surname>Bonaccorsi</surname> <given-names>S</given-names></name><name><surname>Kurek</surname> <given-names>R</given-names></name><name><surname>Farkas</surname> <given-names>RM</given-names></name><name><surname>Dimitri</surname> <given-names>P</given-names></name><name><surname>Fuller</surname> <given-names>MT</given-names></name><name><surname>Gatti</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The class I PITP giotto is required for <italic>Drosophila</italic> cytokinesis</article-title><source>Current Biology</source><volume>16</volume><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.12.011</pub-id><pub-id pub-id-type="pmid">16431372</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulyás</surname> <given-names>M</given-names></name><name><surname>Bencsik</surname> <given-names>N</given-names></name><name><surname>Pusztai</surname> <given-names>S</given-names></name><name><surname>Liliom</surname> <given-names>H</given-names></name><name><surname>Schlett</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>AnimalTracker: An ImageJ-Based Tracking API to Create a Customized Behaviour Analyser Program</article-title><source>Neuroinformatics</source><volume>14</volume><fpage>479</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1007/s12021-016-9303-z</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>VK</given-names></name><name><surname>Scheunemann</surname> <given-names>L</given-names></name><name><surname>Eisenberg</surname> <given-names>T</given-names></name><name><surname>Mertel</surname> <given-names>S</given-names></name><name><surname>Bhukel</surname> <given-names>A</given-names></name><name><surname>Koemans</surname> <given-names>TS</given-names></name><name><surname>Kramer</surname> <given-names>JM</given-names></name><name><surname>Liu</surname> <given-names>KSY</given-names></name><name><surname>Schroeder</surname> <given-names>S</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>Sinner</surname> <given-names>F</given-names></name><name><surname>Magnes</surname> <given-names>C</given-names></name><name><surname>Pieber</surname> <given-names>TR</given-names></name><name><surname>Dipt</surname> <given-names>S</given-names></name><name><surname>Fiala</surname> <given-names>A</given-names></name><name><surname>Schenck</surname> <given-names>A</given-names></name><name><surname>Schwaerzel</surname> <given-names>M</given-names></name><name><surname>Madeo</surname> <given-names>F</given-names></name><name><surname>Sigrist</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>1453</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1038/nn.3512</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huichalaf</surname> <given-names>C</given-names></name><name><surname>Schoser</surname> <given-names>B</given-names></name><name><surname>Schneider-Gold</surname> <given-names>C</given-names></name><name><surname>Jin</surname> <given-names>B</given-names></name><name><surname>Sarkar</surname> <given-names>P</given-names></name><name><surname>Timchenko</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Reduction of the Rate of Protein Translation in Patients with Myotonic Dystrophy 2</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>9042</fpage><lpage>9049</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1983-09.2009</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadevaia</surname> <given-names>V</given-names></name><name><surname>Caldarola</surname> <given-names>S</given-names></name><name><surname>Tino</surname> <given-names>E</given-names></name><name><surname>Amaldi</surname> <given-names>F</given-names></name><name><surname>Loreni</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5'-terminal oligopyrimidine (TOP) mRNAs</article-title><source>RNA</source><volume>14</volume><fpage>1730</fpage><lpage>1736</lpage><pub-id pub-id-type="doi">10.1261/rna.1037108</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiguro</surname> <given-names>T</given-names></name><name><surname>Sato</surname> <given-names>N</given-names></name><name><surname>Ueyama</surname> <given-names>M</given-names></name><name><surname>Fujikake</surname> <given-names>N</given-names></name><name><surname>Sellier</surname> <given-names>C</given-names></name><name><surname>Kanegami</surname> <given-names>A</given-names></name><name><surname>Tokuda</surname> <given-names>E</given-names></name><name><surname>Zamiri</surname> <given-names>B</given-names></name><name><surname>Gall-Duncan</surname> <given-names>T</given-names></name><name><surname>Mirceta</surname> <given-names>M</given-names></name><name><surname>Furukawa</surname> <given-names>Y</given-names></name><name><surname>Yokota</surname> <given-names>T</given-names></name><name><surname>Wada</surname> <given-names>K</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Pearson</surname> <given-names>CE</given-names></name><name><surname>Charlet-Berguerand</surname> <given-names>N</given-names></name><name><surname>Mizusawa</surname> <given-names>H</given-names></name><name><surname>Nagai</surname> <given-names>Y</given-names></name><name><surname>Ishikawa</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31</article-title><source>Neuron</source><volume>94</volume><fpage>108</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.046</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juźwik</surname> <given-names>CA</given-names></name><name><surname>S. Drake</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Paradis-Isler</surname> <given-names>N</given-names></name><name><surname>Sylvester</surname> <given-names>A</given-names></name><name><surname>Amar-Zifkin</surname> <given-names>A</given-names></name><name><surname>Douglas</surname> <given-names>C</given-names></name><name><surname>Morquette</surname> <given-names>B</given-names></name><name><surname>Moore</surname> <given-names>CS</given-names></name><name><surname>Fournier</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>microRNA dysregulation in neurodegenerative diseases: A systematic review</article-title><source>Progress in Neurobiology</source><volume>182</volume><elocation-id>101664</elocation-id><pub-id pub-id-type="doi">10.1016/j.pneurobio.2019.101664</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanadia</surname> <given-names>RN</given-names></name><name><surname>Shin</surname> <given-names>J</given-names></name><name><surname>Yuan</surname> <given-names>Y</given-names></name><name><surname>Beattie</surname> <given-names>SG</given-names></name><name><surname>Wheeler</surname> <given-names>TM</given-names></name><name><surname>Thornton</surname> <given-names>CA</given-names></name><name><surname>Swanson</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy</article-title><source>PNAS</source><volume>103</volume><fpage>11748</fpage><lpage>11753</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604970103</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemaladewi</surname> <given-names>DU</given-names></name><name><surname>Benjamin</surname> <given-names>JS</given-names></name><name><surname>Hyatt</surname> <given-names>E</given-names></name><name><surname>Ivakine</surname> <given-names>EA</given-names></name><name><surname>Cohn</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Increased polyamines as protective disease modifiers in congenital muscular dystrophy</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>1905</fpage><lpage>1912</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy097</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leipheimer</surname> <given-names>J</given-names></name><name><surname>Bloom</surname> <given-names>ALM</given-names></name><name><surname>Baumstark</surname> <given-names>T</given-names></name><name><surname>Panepinto</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CNBP Homologues Gis2 and Znf9 Interact with a Putative G-Quadruplex-Forming 3′ Untranslated Region, Altering Polysome Association and Stress Tolerance in <italic>Cryptococcus neoformans</italic></article-title><source>mSphere</source><volume>3</volume><fpage>e00201</fpage><lpage>e00218</lpage><pub-id pub-id-type="doi">10.1128/mSphere.00201-18</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liquori</surname> <given-names>CL</given-names></name><name><surname>Ricker</surname> <given-names>K</given-names></name><name><surname>Moseley</surname> <given-names>ML</given-names></name><name><surname>Jacobsen</surname> <given-names>JF</given-names></name><name><surname>Kress</surname> <given-names>W</given-names></name><name><surname>Naylor</surname> <given-names>SL</given-names></name><name><surname>Day</surname> <given-names>JW</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9</article-title><source>Science</source><volume>293</volume><fpage>864</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1126/science.1062125</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>P</given-names></name><name><surname>Gupta</surname> <given-names>N</given-names></name><name><surname>Jing</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Age-related changes in polyamines in memory-associated brain structures in rats</article-title><source>Neuroscience</source><volume>155</volume><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.06.033</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateos-Aierdi</surname> <given-names>AJ</given-names></name><name><surname>Goicoechea</surname> <given-names>M</given-names></name><name><surname>Aiastui</surname> <given-names>A</given-names></name><name><surname>Fernández-Torrón</surname> <given-names>R</given-names></name><name><surname>Garcia-Puga</surname> <given-names>M</given-names></name><name><surname>Matheu</surname> <given-names>A</given-names></name><name><surname>de Munain</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Muscle wasting in myotonic dystrophies: a model of premature aging</article-title><source>Frontiers in Aging Neuroscience</source><volume>7</volume><elocation-id>125</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2015.00125</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname> <given-names>A</given-names></name><name><surname>Goodwin</surname> <given-names>M</given-names></name><name><surname>Swanson</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RNA–protein interactions in unstable microsatellite diseases</article-title><source>Brain Research</source><volume>1584</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2014.03.039</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Weng</surname> <given-names>S-M</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS</article-title><source>Science</source><volume>339</volume><fpage>1335</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1126/science.1232927</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moseley</surname> <given-names>ML</given-names></name><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Ikeda</surname> <given-names>Y</given-names></name><name><surname>Gao</surname> <given-names>W</given-names></name><name><surname>Mosemiller</surname> <given-names>AK</given-names></name><name><surname>Daughters</surname> <given-names>RS</given-names></name><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Weatherspoon</surname> <given-names>MR</given-names></name><name><surname>Clark</surname> <given-names>HB</given-names></name><name><surname>Ebner</surname> <given-names>TJ</given-names></name><name><surname>Day</surname> <given-names>JW</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8</article-title><source>Nature Genetics</source><volume>38</volume><fpage>758</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1038/ng1827</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>L</given-names></name><name><surname>Cleary</surname> <given-names>JD</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease</article-title><source>Annual Review of Neuroscience</source><volume>42</volume><fpage>227</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-070918-050405</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paz</surname> <given-names>I</given-names></name><name><surname>Kosti</surname> <given-names>I</given-names></name><name><surname>Ares</surname> <given-names>M</given-names></name><name><surname>Cline</surname> <given-names>M</given-names></name><name><surname>Mandel-Gutfreund</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RBPmap: a web server for mapping binding sites of RNA-binding proteins</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W361</fpage><lpage>W367</lpage><pub-id pub-id-type="doi">10.1093/nar/gku406</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pegg</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Regulation of Ornithine Decarboxylase</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>14529</fpage><lpage>14532</lpage><pub-id pub-id-type="doi">10.1074/jbc.R500031200</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perbellini</surname> <given-names>R</given-names></name><name><surname>Greco</surname> <given-names>S</given-names></name><name><surname>Sarra-Ferraris</surname> <given-names>G</given-names></name><name><surname>Cardani</surname> <given-names>R</given-names></name><name><surname>Capogrossi</surname> <given-names>MC</given-names></name><name><surname>Meola</surname> <given-names>G</given-names></name><name><surname>Martelli</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1</article-title><source>Neuromuscular Disorders</source><volume>21</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.nmd.2010.11.012</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyronnet</surname> <given-names>S</given-names></name><name><surname>Pradayrol</surname> <given-names>L</given-names></name><name><surname>Sonenberg</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A Cell Cycle–Dependent Internal Ribosome Entry Site</article-title><source>Molecular Cell</source><volume>5</volume><fpage>607</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80240-3</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raheem</surname> <given-names>O</given-names></name><name><surname>Olufemi</surname> <given-names>S-E</given-names></name><name><surname>Bachinski</surname> <given-names>LL</given-names></name><name><surname>Vihola</surname> <given-names>A</given-names></name><name><surname>Sirito</surname> <given-names>M</given-names></name><name><surname>Holmlund-Hampf</surname> <given-names>J</given-names></name><name><surname>Haapasalo</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>Y-P</given-names></name><name><surname>Udd</surname> <given-names>B</given-names></name><name><surname>Krahe</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2</article-title><source>The American Journal of Pathology</source><volume>177</volume><fpage>3025</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.100179</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rom</surname> <given-names>E</given-names></name><name><surname>Kahana</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Isolation and Characterization of the <italic>Drosophila</italic> Ornithine Decarboxylase Locus: Evidence for the Presence of Two Transcribed ODC Genes in the <italic>Drosophila</italic> Genome</article-title><source>DNA and Cell Biology</source><volume>12</volume><fpage>499</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1089/dna.1993.12.499</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salisbury</surname> <given-names>E</given-names></name><name><surname>Schoser</surname> <given-names>B</given-names></name><name><surname>Schneider-Gold</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>G-L</given-names></name><name><surname>Huichalaf</surname> <given-names>C</given-names></name><name><surname>Jin</surname> <given-names>B</given-names></name><name><surname>Sirito</surname> <given-names>M</given-names></name><name><surname>Sarkar</surname> <given-names>P</given-names></name><name><surname>Krahe</surname> <given-names>R</given-names></name><name><surname>Timchenko</surname> <given-names>NA</given-names></name><name><surname>Timchenko</surname> <given-names>LT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Expression of RNA CCUG Repeats Dysregulates Translation and Degradation of Proteins in Myotonic Dystrophy 2 Patients</article-title><source>The American Journal of Pathology</source><volume>175</volume><fpage>748</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2009.090047</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sammons</surname> <given-names>MA</given-names></name><name><surname>Samir</surname> <given-names>P</given-names></name><name><surname>Link</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title><italic>Saccharomyces cerevisiae</italic> Gis2 interacts with the translation machinery and is orthogonal to myotonic dystrophy type 2 protein ZNF9</article-title><source>Biochemical and Biophysical Research Communications</source><volume>406</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.01.086</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider-Gold</surname> <given-names>C</given-names></name><name><surname>Timchenko</surname> <given-names>LT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CCUG Repeats Reduce the Rate of Global Protein Synthesis in Myotonic Dystrophy Type 2</article-title><source>Reviews in the Neurosciences</source><volume>21</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1515/REVNEURO.2010.21.1.19</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somma</surname> <given-names>MP</given-names></name><name><surname>Ceprani</surname> <given-names>F</given-names></name><name><surname>Bucciarelli</surname> <given-names>E</given-names></name><name><surname>Naim</surname> <given-names>V</given-names></name><name><surname>De Arcangelis</surname> <given-names>V</given-names></name><name><surname>Piergentili</surname> <given-names>R</given-names></name><name><surname>Palena</surname> <given-names>A</given-names></name><name><surname>Ciapponi</surname> <given-names>L</given-names></name><name><surname>Giansanti</surname> <given-names>MG</given-names></name><name><surname>Pellacani</surname> <given-names>C</given-names></name><name><surname>Petrucci</surname> <given-names>R</given-names></name><name><surname>Cenci</surname> <given-names>G</given-names></name><name><surname>Vernì</surname> <given-names>F</given-names></name><name><surname>Fasulo</surname> <given-names>B</given-names></name><name><surname>Goldberg</surname> <given-names>ML</given-names></name><name><surname>Di Cunto</surname> <given-names>F</given-names></name><name><surname>Gatti</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of <italic>Drosophila</italic> Mitotic Genes by Combining Co-Expression Analysis and RNA Interference</article-title><source>PLOS Genetics</source><volume>4</volume><elocation-id>e1000126</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000126</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soragni</surname> <given-names>E</given-names></name><name><surname>Petrosyan</surname> <given-names>L</given-names></name><name><surname>Rinkoski</surname> <given-names>TA</given-names></name><name><surname>Wieben</surname> <given-names>ED</given-names></name><name><surname>Baratz</surname> <given-names>KH</given-names></name><name><surname>Fautsch</surname> <given-names>MP</given-names></name><name><surname>Gottesfeld</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Repeat-Associated Non-ATG (RAN) Translation in Fuchs' Endothelial Corneal Dystrophy</article-title><source>Investigative Opthalmology &amp; Visual Science</source><volume>59</volume><fpage>1888</fpage><lpage>1896</lpage><pub-id pub-id-type="doi">10.1167/iovs.17-23265</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname> <given-names>PK</given-names></name><name><surname>Oh</surname> <given-names>SY</given-names></name><name><surname>Krans</surname> <given-names>A</given-names></name><name><surname>He</surname> <given-names>F</given-names></name><name><surname>Sellier</surname> <given-names>C</given-names></name><name><surname>Frazer</surname> <given-names>M</given-names></name><name><surname>Renoux</surname> <given-names>AJ</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Scaglione</surname> <given-names>KM</given-names></name><name><surname>Basrur</surname> <given-names>V</given-names></name><name><surname>Elenitoba-Johnson</surname> <given-names>K</given-names></name><name><surname>Vonsattel</surname> <given-names>JP</given-names></name><name><surname>Louis</surname> <given-names>ED</given-names></name><name><surname>Sutton</surname> <given-names>MA</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Mills</surname> <given-names>RE</given-names></name><name><surname>Charlet-Berguerand</surname> <given-names>N</given-names></name><name><surname>Paulson</surname> <given-names>HL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome</article-title><source>Neuron</source><volume>78</volume><fpage>440</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.026</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname> <given-names>WH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The physiological role of the polyamines</article-title><source>European Journal of Clinical Investigation</source><volume>30</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2362.2000.00585.x</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname> <given-names>HM</given-names></name><name><surname>Fraser</surname> <given-names>AV</given-names></name><name><surname>Hughes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A perspective of polyamine metabolism</article-title><source>Biochemical Journal</source><volume>376</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1042/bj20031327</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>C</given-names></name><name><surname>Stock</surname> <given-names>L</given-names></name><name><surname>Schneider-Gold</surname> <given-names>C</given-names></name><name><surname>Sommer</surname> <given-names>C</given-names></name><name><surname>Timchenko</surname> <given-names>NA</given-names></name><name><surname>Timchenko</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Reduction of cellular nucleic acid binding protein encoded by a myotonic dystrophy type 2 gene causes muscle atrophy</article-title><source>Molecular and Cellular Biology</source><volume>38</volume><elocation-id>e00649-17</elocation-id><pub-id pub-id-type="doi">10.1128/MCB.00649-17</pub-id><pub-id pub-id-type="pmid">29735719</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>Z</given-names></name><name><surname>Goodman</surname> <given-names>LD</given-names></name><name><surname>Shieh</surname> <given-names>S-Y</given-names></name><name><surname>Min</surname> <given-names>M</given-names></name><name><surname>Teng</surname> <given-names>X</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Bonini</surname> <given-names>NM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>954</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu507</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Gibbens</surname> <given-names>B</given-names></name><name><surname>Doty</surname> <given-names>NS</given-names></name><name><surname>Gomes-Pereira</surname> <given-names>M</given-names></name><name><surname>Huguet</surname> <given-names>A</given-names></name><name><surname>Stone</surname> <given-names>MD</given-names></name><name><surname>Margolis</surname> <given-names>J</given-names></name><name><surname>Peterson</surname> <given-names>M</given-names></name><name><surname>Markowski</surname> <given-names>TW</given-names></name><name><surname>Ingram</surname> <given-names>MAC</given-names></name><name><surname>Nan</surname> <given-names>Z</given-names></name><name><surname>Forster</surname> <given-names>C</given-names></name><name><surname>Low</surname> <given-names>WC</given-names></name><name><surname>Schoser</surname> <given-names>B</given-names></name><name><surname>Somia</surname> <given-names>NV</given-names></name><name><surname>Clark</surname> <given-names>HB</given-names></name><name><surname>Schmechel</surname> <given-names>S</given-names></name><name><surname>Bitterman</surname> <given-names>PB</given-names></name><name><surname>Gourdon</surname> <given-names>G</given-names></name><name><surname>Swanson</surname> <given-names>MS</given-names></name><name><surname>Moseley</surname> <given-names>M</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Non-ATG–initiated translation directed by microsatellite expansions</article-title><source>PNAS</source><volume>108</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1073/pnas.1013343108</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Banez-Coronel</surname> <given-names>M</given-names></name><name><surname>Reid</surname> <given-names>T</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Lewis</surname> <given-names>J</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Falchook</surname> <given-names>AE</given-names></name><name><surname>Subramony</surname> <given-names>SH</given-names></name><name><surname>Ostrow</surname> <given-names>LW</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia</article-title><source>PNAS</source><volume>110</volume><fpage>E4968</fpage><lpage>E4977</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315438110</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Cleary</surname> <given-names>JD</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Bañez-Coronel</surname> <given-names>M</given-names></name><name><surname>Bubenik</surname> <given-names>JL</given-names></name><name><surname>Ayhan</surname> <given-names>F</given-names></name><name><surname>Ashizawa</surname> <given-names>T</given-names></name><name><surname>Xia</surname> <given-names>G</given-names></name><name><surname>Clark</surname> <given-names>HB</given-names></name><name><surname>Yachnis</surname> <given-names>AT</given-names></name><name><surname>Swanson</surname> <given-names>MS</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2</article-title><source>Neuron</source><volume>95</volume><fpage>1292</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.039</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69269.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Ramaswami</surname><given-names>Mani</given-names></name><role>Reviewing Editor</role><aff><institution>Trinity College Dublin</institution><country>Ireland</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ramaswami</surname><given-names>Mani</given-names> </name><role>Reviewer</role><aff><institution>Trinity College Dublin</institution><country>Ireland</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.04.29.441910">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.04.29.441910v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This interesting study in <italic>Drosophila</italic> suggests that at least part of the pathology of DM2, a certain form of muscular dystrophy, is caused by defects in a gene that is required for the production of small molecules, called polyamines which are known to support muscle health and function. Observations in a <italic>Drosophila</italic> model of DM2 show that feeding with polyamines can restore muscle function, Taken together with observations muscle biopsies from human DM2 patients also show decreased levels of polyamines and ODC, a key enzyme in polyamine metabolism, this work raises possibility of using polyamines for therapy or prevention.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Translational control of polyamine metabolism by CNBP is required for locomotor function in <italic>Drosophila melanogaster</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Mani Ramaswami as Reviewing Editor and Reviewer #1, and K VijayRaghavan as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) One finding that is puzzling and could be better explained is shown in Figure 4 supplement: why is the reduction of putrescine levels the same when either the ODC1 or ODC2 gene is knocked down alone and when both genes are targeted at the same time? Shouldn't the double knock down show a stronger effect?</p><p>2) None of the western blots are quantified and there does not appear to be any replicates for most of them. This is important to show, especially when the authors comment on the levels of a particular protein being affected, it is hard to know how strong a reduction is without appropriate quantification relative to a housekeeping gene. Ideally, all western blots would need quantifying, but the most important ones would be Figure 1D, Figure 3A, Figure 3-S1, Figure 5A Figure 5S, Figure 6-S3.</p><p>3) Table 1, did the authors check the levels of knock-down for the neuronal drivers? RNAi in brain of flies is often difficult to achieve, it is important to determine this, to ensure that the reason there is no phenotype with neuronal drivers is not simply because there is no knock-down. Alternatively, the caveat should be acknowledged and it should be formally noted that potential brain function has not yet been excluded by the current analysis.</p><p>4) Lines 244-246, if patient tissue samples are available the authors should perform (and if not should indicate the need for) further direct analysis to formally demonstrate differential splicing in DM2 patients</p><p>5) Figure 7C there is no quantification of the CNBP knock-down when dOdc1 is over-expressed, this is important as the rescue could be due to a diluting out of the Gal4 driver (given there are now 3 transgenes in that fly), this would lead to a reduced knock-down and the rescue could be due to the CNBP levels increasing again.</p><p>6) For the ageing experiments in Figure 7 to be completely convincing, the authors would need to back-cross all their lines into a homogeneous back-ground 6 times, as back-ground variation has a very strong effect on speed of ageing. Also, to show that this reduction is not an effect of developmental defects, the authors should down-regulate CNBP post-eclosion, either using the Gal4/Gal80 system or the Gene-Switch system. Given how long these experiments would take, unless data are available, this section and relevant discussion should be duly abbreviated and/or qualified to acknowledge limitations of conclusions based on these data..</p><p>7) Lines 351-353: The authors use mutant CNBP for part of their characterisation, this would be a full animal knock-down, does this animal display muscle defects?</p><p>8) Gene names and abbreviations should be defined in the abstract and the first time they are mentioned in the text</p><p>9) Full genotypes should be written out in the figure legends for clarity</p><p>10) the conditions of fly rearing should be outlines in the methods (temperature/humidity/light dark cycle/food recipe) for stocks and experiments</p><p>11) Figure 1A represents a video, but this does not come across in a PDF, which is how most people will visualise the paper, maybe a plot/trace of the locomotor activity can be included and the videos included in supplemental methods.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69269.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) One finding that is puzzling and could be better explained is shown in Figure 4 supplement: why is the reduction of putrescine levels the same when either the ODC1 or ODC2 gene is knocked down alone and when both genes are targeted at the same time? Shouldn't the double knock down show a stronger effect?</p></disp-quote><p>We thank the referees and editors for the question raised. We agree that if both Odc1 and Odc2 cause a decrease of putrescine content, it would be expected that depletion of both isoforms should result in a more pronounced depletion of this polyamine. However, it should be pointed out that intracellular putrescine pool is not only the result of ODC-mediated ornithine decarboxylation but it is also produced from coupled acetylation/oxidation of spermine and spermidine and from the intake of extracellular polyamines, through specific transmembrane transporters (Casero et al., 2018). Hence, in case of complete blockade of ODC activity, putrescine could not be fully depleted thanks to these additional mechanisms. As for individual Odc1 and Odc2 knockdown, it is likely that both isoforms contribute to the intracellular putrescine pool and that stable ablation of each of them causes a comparable putrescine depletion as a result of activation of the compensatory mechanisms described above.</p><p>These issues have been discussed in the revised manuscript (lines 214-219).</p><disp-quote content-type="editor-comment"><p>2) None of the western blots are quantified and there does not appear to be any replicates for most of them. This is important to show, especially when the authors comment on the levels of a particular protein being affected, it is hard to know how strong a reduction is without appropriate quantification relative to a housekeeping gene. Ideally, all western blots would need quantifying, but the most important ones would be Figure 1D, Figure 3A, Figure 3-S1, Figure 5A Figure 5S, Figure 6-S3.</p></disp-quote><p>We agree that quantification of western blots band intensity is important. Thus, we have quantified all western blots using the ImageJ software. The graph representations have been included for each corresponding figure.</p><p>In particular: WB of Figure 1D has been moved to Figure 1E, which now includes the corresponding quantification graph; WB of Figure 2 has been moved to Figure 2B, which now includes the corresponding quantification graph; in Figure 3A, 3-S1A, 5A and 5-S1 the corresponding quantification graph of each WB has been included; the band quantifications of the WBs shown in both Figure 6B and D are shown in the new Figure 6-S3A and B; in Figure 6-S4 (before Figure 6-S3) the corresponding quantification graph of the WB has been included (Figure 6-S4A).</p><p>All row data obtained from quantifications and used to generate the column graphs have been included as source data.</p><disp-quote content-type="editor-comment"><p>3) Table 1, did the authors check the levels of knock-down for the neuronal drivers? RNAi in brain of flies is often difficult to achieve, it is important to determine this, to ensure that the reason there is no phenotype with neuronal drivers is not simply because there is no knock-down. Alternatively, the caveat should be acknowledged and it should be formally noted that potential brain function has not yet been excluded by the current analysis.</p></disp-quote><p>To verify that the absence of phenotype observed with the neuronal drivers is not due to a reduced efficacy of the dCNBP knockdown, we analyzed the expression levels of the dCNBP protein in both larval or adult brains when the UAS-CNBP RNAi constructs were expressed under the control of either the <italic>n-syb</italic> or <italic>elav</italic> GAL4 driver. These results are presented in an additional supplementary figure (Figure 1, figure supplement 1), where an immunoblot shows that both larval or adult brains are almost completely depleted of the dCNBP protein (bands quantification has also been included in the figure). These results have been also discussed in the revised manuscript (lines 148-149). Unfortunately, we were not able to test the depletion of dCNBP with other GAL4 drivers causing absence of phenotype, such as 5053-, sr<sup>md710</sup>- or repo- GAL4, because in those drivers the GAL4 expression is limited to few specific cells, and the presence of not-depleted cells could contaminate the immunoblot analysis.</p><disp-quote content-type="editor-comment"><p>4) Lines 244-246, if patient tissue samples are available the authors should perform (and if not should indicate the need for) further direct analysis to formally demonstrate differential splicing in DM2 patients</p></disp-quote><p>We agree that further experimentation to demonstrate the mechanism underlying the reduced levels of CNBP would be of interest. Unfortunately, the amount of samples (muscle biopsies from patients) was very little and we had to use all the available material to measure polyamines and protein content, as shown in the manuscript. Our analysis shows that in transgenic flies expressing quadruplet expansion the levels of CNBP were not reduced, indicating that the downregulation is not linked to RNA toxicity and suggesting that the reduced content of CNBP protein is likely the consequence of other mechanisms, specifically related to the intronic mutations occurring within the human <italic>CNBP/ZNF9</italic> gene.</p><p>Further studies with muscle samples from patients will be required to elucidate this issue.</p><p>These considerations have been added to the revised manuscript (lines 235-239).</p><disp-quote content-type="editor-comment"><p>5) Figure 7C there is no quantification of the CNBP knock-down when dOdc1 is over-expressed, this is important as the rescue could be due to a diluting out of the Gal4 driver (given there are now 3 transgenes in that fly), this would lead to a reduced knock-down and the rescue could be due to the CNBP levels increasing again.</p></disp-quote><p>We agree with referees that dilution of GAL4 by the presence of additional transgenes is a tangible problem in the UAS-GAL4 binary system. In order to address this point, we have quantified the expression levels of dCNBP protein in dCNBP interfered individuals, either in the presence or in the absence of the <italic>UAS-Odc1</italic> transgene. This result is included in an additional supplementary figure (named Figure 7—figure supplement 2), where an immunoblot shows that the downregulation of CNBP protein induced by the <italic>UAS-RNAi</italic> constructs is not affected by presence of the <italic>UAS-dOdc1</italic> construct (bands quantification has also been included in the figure). This result is discussed in the revised manuscript (lines 291-294).</p><disp-quote content-type="editor-comment"><p>6) For the ageing experiments in Figure 7 to be completely convincing, the authors would need to back-cross all their lines into a homogeneous back-ground 6 times, as back-ground variation has a very strong effect on speed of ageing. Also, to show that this reduction is not an effect of developmental defects, the authors should down-regulate CNBP post-eclosion, either using the Gal4/Gal80 system or the Gene-Switch system. Given how long these experiments would take, unless data are available, this section and relevant discussion should be duly abbreviated and/or qualified to acknowledge limitations of conclusions based on these data..</p></disp-quote><p>We agree with referees that backcrossing our lines would exclude the influence of the genetic background heterogeneity on aging and that CNBP silencing post-eclosion would exclude the effects of developmental defects in aging acceleration. However, as noted by referees these experiments would take too much time to get clear and exhaustive answers. As suggested by the referees, we have acknowledged the limitation of these experimental conditions in the revised manuscript. We have significantly toned down our statements and highlighted that this is an interesting observation that poses attractive hypotheses (lines 305/308-312).</p><disp-quote content-type="editor-comment"><p>7) Lines 351-353: The authors use mutant CNBP for part of their characterisation, this would be a full animal knock-down, does this animal display muscle defects?</p></disp-quote><p>As suggested, we have performed analysis of muscle structure in mutant CNBP flies. As shown in the additional panel included in Figure 7—figure supplement 4 (before Figure 7—figure supplement 3) we did not see clear differences in muscle morphology in CNBP mutant larvae compared to controls. In this regard, it must be pointed out that while CNBP mutant animals die early during larval development (2nd instar), a significant fraction of CNBP homozygous KO mice are viable at birth, when the muscle phenotype is detected (Wei et al., 2018). Hence, it is possible that such a short survival of CNBP mutant flies does not allow sufficient time for the muscle alterations to fully develop and be appreciated. Moreover, we cannot exclude that an early requirement of CNBP for muscle development might be overshadowed by the presence of maternal contribution provided by the heterozygous mother flies. Further studies will help to understand this issue.</p><p>These points have been included in the revised manuscript (lines 351-360).</p><disp-quote content-type="editor-comment"><p>8) Gene names and abbreviations should be defined in the abstract and the first time they are mentioned in the text9) Full genotypes should be written out in the figure legends for clarity</p><p>10) the conditions of fly rearing should be outlines in the methods (temperature/humidity/light dark cycle/food recipe) for stocks and experiments</p></disp-quote><p>We have defined all abbreviations in the abstract and the first time they are mentioned. In figure legends all genotypes have been fully written and Materials and methods now specify the conditions of fly rearing (lines 425-428). Moreover, specific experimental conditions are always reported in the figure legend.</p><disp-quote content-type="editor-comment"><p>11) Figure 1A represents a video, but this does not come across in a PDF, which is how most people will visualise the paper, maybe a plot/trace of the locomotor activity can be included and the videos included in supplemental methods.</p></disp-quote><p>We completely agree with referees that it is essential to represent the biological message displayed by the fly's videos as a still image, compatible with a PDF version of the manuscript. To this end, we took advantage of a specific ImageJ plugin, named animal tracker, that allowed us to analyze the recorded fly movement and to quantify both fly speed and distance covered in one minute. These data have been included in a new Figure 1A and discussed in the revised manuscript (lines 153-156).</p></body></sub-article></article>